FALSE 2024 Q3 0000877212 12/31 http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:EUR iso4217:GBP iso4217:JPY iso4217:SGD iso4217:MXN iso4217:PLN xbrli:pure zbra:segment 0000877212 2024-01-01 2024-09-28 0000877212 2024-10-22 0000877212 2024-09-28 0000877212 2023-12-31 0000877212 zbra:TangibleProductsMember 2024-06-30 2024-09-28 0000877212 zbra:TangibleProductsMember 2023-07-02 2023-09-30 0000877212 zbra:TangibleProductsMember 2024-01-01 2024-09-28 0000877212 zbra:TangibleProductsMember 2023-01-01 2023-09-30 0000877212 zbra:ServiceAndSoftwareMember 2024-06-30 2024-09-28 0000877212 zbra:ServiceAndSoftwareMember 2023-07-02 2023-09-30 0000877212 zbra:ServiceAndSoftwareMember 2024-01-01 2024-09-28 0000877212 zbra:ServiceAndSoftwareMember 2023-01-01 2023-09-30 0000877212 2024-06-30 2024-09-28 0000877212 2023-07-02 2023-09-30 0000877212 2023-01-01 2023-09-30 0000877212 us-gaap:CommonStockMember 2023-12-31 0000877212 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000877212 us-gaap:TreasuryStockCommonMember 2023-12-31 0000877212 us-gaap:RetainedEarningsMember 2023-12-31 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000877212 us-gaap:CommonStockMember 2024-01-01 2024-03-30 0000877212 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-30 0000877212 2024-01-01 2024-03-30 0000877212 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-30 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-30 0000877212 us-gaap:CommonStockMember 2024-03-30 0000877212 us-gaap:AdditionalPaidInCapitalMember 2024-03-30 0000877212 us-gaap:TreasuryStockCommonMember 2024-03-30 0000877212 us-gaap:RetainedEarningsMember 2024-03-30 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-30 0000877212 2024-03-30 0000877212 us-gaap:CommonStockMember 2024-03-31 2024-06-29 0000877212 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 2024-06-29 0000877212 us-gaap:TreasuryStockCommonMember 2024-03-31 2024-06-29 0000877212 2024-03-31 2024-06-29 0000877212 us-gaap:RetainedEarningsMember 2024-03-31 2024-06-29 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 2024-06-29 0000877212 us-gaap:CommonStockMember 2024-06-29 0000877212 us-gaap:AdditionalPaidInCapitalMember 2024-06-29 0000877212 us-gaap:TreasuryStockCommonMember 2024-06-29 0000877212 us-gaap:RetainedEarningsMember 2024-06-29 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-29 0000877212 2024-06-29 0000877212 us-gaap:CommonStockMember 2024-06-30 2024-09-28 0000877212 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 2024-09-28 0000877212 us-gaap:TreasuryStockCommonMember 2024-06-30 2024-09-28 0000877212 us-gaap:RetainedEarningsMember 2024-06-30 2024-09-28 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 2024-09-28 0000877212 us-gaap:CommonStockMember 2024-09-28 0000877212 us-gaap:AdditionalPaidInCapitalMember 2024-09-28 0000877212 us-gaap:TreasuryStockCommonMember 2024-09-28 0000877212 us-gaap:RetainedEarningsMember 2024-09-28 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-28 0000877212 us-gaap:CommonStockMember 2022-12-31 0000877212 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000877212 us-gaap:TreasuryStockCommonMember 2022-12-31 0000877212 us-gaap:RetainedEarningsMember 2022-12-31 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000877212 2022-12-31 0000877212 us-gaap:CommonStockMember 2023-01-01 2023-04-01 0000877212 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-04-01 0000877212 2023-01-01 2023-04-01 0000877212 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-04-01 0000877212 us-gaap:RetainedEarningsMember 2023-01-01 2023-04-01 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-04-01 0000877212 us-gaap:CommonStockMember 2023-04-01 0000877212 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 0000877212 us-gaap:TreasuryStockCommonMember 2023-04-01 0000877212 us-gaap:RetainedEarningsMember 2023-04-01 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 0000877212 2023-04-01 0000877212 us-gaap:CommonStockMember 2023-04-02 2023-07-01 0000877212 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 2023-07-01 0000877212 us-gaap:TreasuryStockCommonMember 2023-04-02 2023-07-01 0000877212 2023-04-02 2023-07-01 0000877212 us-gaap:RetainedEarningsMember 2023-04-02 2023-07-01 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 2023-07-01 0000877212 us-gaap:CommonStockMember 2023-07-01 0000877212 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 0000877212 us-gaap:TreasuryStockCommonMember 2023-07-01 0000877212 us-gaap:RetainedEarningsMember 2023-07-01 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 0000877212 2023-07-01 0000877212 us-gaap:CommonStockMember 2023-07-02 2023-09-30 0000877212 us-gaap:TreasuryStockCommonMember 2023-07-02 2023-09-30 0000877212 us-gaap:AdditionalPaidInCapitalMember 2023-07-02 2023-09-30 0000877212 us-gaap:RetainedEarningsMember 2023-07-02 2023-09-30 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 2023-09-30 0000877212 us-gaap:CommonStockMember 2023-09-30 0000877212 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000877212 us-gaap:TreasuryStockCommonMember 2023-09-30 0000877212 us-gaap:RetainedEarningsMember 2023-09-30 0000877212 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000877212 2023-09-30 0000877212 zbra:TangibleProductsMember zbra:AssetIntelligenceTrackingAITMember 2024-06-30 2024-09-28 0000877212 zbra:ServiceAndSoftwareMember zbra:AssetIntelligenceTrackingAITMember 2024-06-30 2024-09-28 0000877212 zbra:AssetIntelligenceTrackingAITMember 2024-06-30 2024-09-28 0000877212 zbra:TangibleProductsMember zbra:AssetIntelligenceTrackingAITMember 2023-07-02 2023-09-30 0000877212 zbra:ServiceAndSoftwareMember zbra:AssetIntelligenceTrackingAITMember 2023-07-02 2023-09-30 0000877212 zbra:AssetIntelligenceTrackingAITMember 2023-07-02 2023-09-30 0000877212 zbra:TangibleProductsMember zbra:EnterpriseVisibilityMobilityEVMMember 2024-06-30 2024-09-28 0000877212 zbra:ServiceAndSoftwareMember zbra:EnterpriseVisibilityMobilityEVMMember 2024-06-30 2024-09-28 0000877212 zbra:EnterpriseVisibilityMobilityEVMMember 2024-06-30 2024-09-28 0000877212 zbra:TangibleProductsMember zbra:EnterpriseVisibilityMobilityEVMMember 2023-07-02 2023-09-30 0000877212 zbra:ServiceAndSoftwareMember zbra:EnterpriseVisibilityMobilityEVMMember 2023-07-02 2023-09-30 0000877212 zbra:EnterpriseVisibilityMobilityEVMMember 2023-07-02 2023-09-30 0000877212 zbra:TangibleProductsMember zbra:AssetIntelligenceTrackingAITMember 2024-01-01 2024-09-28 0000877212 zbra:ServiceAndSoftwareMember zbra:AssetIntelligenceTrackingAITMember 2024-01-01 2024-09-28 0000877212 zbra:AssetIntelligenceTrackingAITMember 2024-01-01 2024-09-28 0000877212 zbra:TangibleProductsMember zbra:AssetIntelligenceTrackingAITMember 2023-01-01 2023-09-30 0000877212 zbra:ServiceAndSoftwareMember zbra:AssetIntelligenceTrackingAITMember 2023-01-01 2023-09-30 0000877212 zbra:AssetIntelligenceTrackingAITMember 2023-01-01 2023-09-30 0000877212 zbra:TangibleProductsMember zbra:EnterpriseVisibilityMobilityEVMMember 2024-01-01 2024-09-28 0000877212 zbra:ServiceAndSoftwareMember zbra:EnterpriseVisibilityMobilityEVMMember 2024-01-01 2024-09-28 0000877212 zbra:EnterpriseVisibilityMobilityEVMMember 2024-01-01 2024-09-28 0000877212 zbra:TangibleProductsMember zbra:EnterpriseVisibilityMobilityEVMMember 2023-01-01 2023-09-30 0000877212 zbra:ServiceAndSoftwareMember zbra:EnterpriseVisibilityMobilityEVMMember 2023-01-01 2023-09-30 0000877212 zbra:EnterpriseVisibilityMobilityEVMMember 2023-01-01 2023-09-30 0000877212 2024-09-29 2024-09-28 0000877212 2024-01-01 2023-12-31 0000877212 us-gaap:FairValueInputsLevel1Member zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel2Member zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel3Member zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel1Member 2024-09-28 0000877212 us-gaap:FairValueInputsLevel2Member 2024-09-28 0000877212 us-gaap:FairValueInputsLevel3Member 2024-09-28 0000877212 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignExchangeContractMember 2024-09-28 0000877212 us-gaap:ForeignExchangeContractMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel1Member zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel2Member zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel3Member zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2024-09-28 0000877212 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwapMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwapMember 2023-12-31 0000877212 us-gaap:InterestRateSwapMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel1Member zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel2Member zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel3Member zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 zbra:InvestmentsRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel1Member 2023-12-31 0000877212 us-gaap:FairValueInputsLevel2Member 2023-12-31 0000877212 us-gaap:FairValueInputsLevel3Member 2023-12-31 0000877212 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignExchangeContractMember 2023-12-31 0000877212 us-gaap:ForeignExchangeContractMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel1Member zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel2Member zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 us-gaap:FairValueInputsLevel3Member zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 zbra:LiabilitiesRelatedToDeferredCompensationPlanMember 2023-12-31 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccruedLiabilitiesMember 2024-09-28 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccruedLiabilitiesMember 2023-12-31 0000877212 us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-28 0000877212 us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-09-28 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-12-31 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherNoncurrentAssetsMember 2024-09-28 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherNoncurrentAssetsMember 2023-12-31 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2024-09-28 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2023-12-31 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2024-09-28 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:AccruedLiabilitiesMember 2023-12-31 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherNoncurrentLiabilitiesMember 2024-09-28 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-12-31 0000877212 us-gaap:NondesignatedMember 2024-09-28 0000877212 us-gaap:NondesignatedMember 2023-12-31 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-06-30 2024-09-28 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-07-02 2023-09-30 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-01-01 2024-09-28 0000877212 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 2023-09-30 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2024-06-30 2024-09-28 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2023-07-02 2023-09-30 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2024-01-01 2024-09-28 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2023-01-01 2023-09-30 0000877212 us-gaap:NondesignatedMember 2024-06-30 2024-09-28 0000877212 us-gaap:NondesignatedMember 2023-07-02 2023-09-30 0000877212 us-gaap:NondesignatedMember 2024-01-01 2024-09-28 0000877212 us-gaap:NondesignatedMember 2023-01-01 2023-09-30 0000877212 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2024-03-31 2024-06-29 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-09-28 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 2024-09-28 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-07-02 2023-09-30 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-09-30 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-28 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2024-01-01 2024-09-28 0000877212 zbra:BritishPoundUSDollarForwardContractMember us-gaap:NondesignatedMember 2024-09-28 0000877212 zbra:BritishPoundUSDollarForwardContractMember us-gaap:NondesignatedMember 2023-12-31 0000877212 zbra:EuroUSDollarForwardContractMember us-gaap:NondesignatedMember 2024-09-28 0000877212 zbra:EuroUSDollarForwardContractMember us-gaap:NondesignatedMember 2023-12-31 0000877212 zbra:EuroCzechKorunaForwardContractMember us-gaap:NondesignatedMember 2024-09-28 0000877212 zbra:EuroCzechKorunaForwardContractMember us-gaap:NondesignatedMember 2023-12-31 0000877212 zbra:JapaneseYenUSDollarForwardContractMember us-gaap:NondesignatedMember 2024-09-28 0000877212 zbra:JapaneseYenUSDollarForwardContractMember us-gaap:NondesignatedMember 2023-12-31 0000877212 zbra:SingaporeDollarUSDollarForwardContractMember us-gaap:NondesignatedMember 2024-09-28 0000877212 zbra:SingaporeDollarUSDollarForwardContractMember us-gaap:NondesignatedMember 2023-12-31 0000877212 zbra:MexicanPesoUSDollarForwardContractMember us-gaap:NondesignatedMember 2024-09-28 0000877212 zbra:MexicanPesoUSDollarForwardContractMember us-gaap:NondesignatedMember 2023-12-31 0000877212 zbra:PolishZlotyUSDollarForwardContractMember us-gaap:NondesignatedMember 2024-09-28 0000877212 zbra:PolishZlotyUSDollarForwardContractMember us-gaap:NondesignatedMember 2023-12-31 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2024-09-28 0000877212 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2023-12-31 0000877212 zbra:TermLoanAMember us-gaap:LoansPayableMember 2024-09-28 0000877212 zbra:TermLoanAMember us-gaap:LoansPayableMember 2023-12-31 0000877212 zbra:A6.5FixedRateSeniorUnsecuredNotesMember us-gaap:SeniorNotesMember 2024-09-28 0000877212 zbra:A6.5FixedRateSeniorUnsecuredNotesMember us-gaap:SeniorNotesMember 2023-12-31 0000877212 us-gaap:RevolvingCreditFacilityMember 2024-09-28 0000877212 us-gaap:RevolvingCreditFacilityMember 2023-12-31 0000877212 zbra:ReceivableFinancingFacilitiesMember us-gaap:SecuredDebtMember 2024-09-28 0000877212 zbra:ReceivableFinancingFacilitiesMember us-gaap:SecuredDebtMember 2023-12-31 0000877212 zbra:A6.5FixedRateSeniorUnsecuredNotesMember us-gaap:SeniorNotesMember 2024-06-29 0000877212 zbra:A6.5FixedRateSeniorUnsecuredNotesMember us-gaap:SeniorNotesMember 2024-03-31 2024-06-29 0000877212 zbra:AmendedandRestatedCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2024-09-28 0000877212 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0000877212 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000877212 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-09-30 0000877212 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-09-30 0000877212 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0000877212 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0000877212 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0000877212 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000877212 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-09-28 0000877212 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-09-28 0000877212 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-09-28 0000877212 us-gaap:AccumulatedTranslationAdjustmentMember 2024-09-28 0000877212 zbra:EMEAAndAsiaPacificMember 2024-06-29 0000877212 zbra:EMEAAndAsiaPacificMember 2024-09-28 0000877212 zbra:EMEAAndAsiaPacificMember srt:ScenarioForecastMember 2024-12-31 0000877212 us-gaap:EMEAMember 2024-09-28 0000877212 us-gaap:OperatingSegmentsMember zbra:AssetIntelligenceTrackingAITMember 2024-06-30 2024-09-28 0000877212 us-gaap:OperatingSegmentsMember zbra:AssetIntelligenceTrackingAITMember 2023-07-02 2023-09-30 0000877212 us-gaap:OperatingSegmentsMember zbra:AssetIntelligenceTrackingAITMember 2024-01-01 2024-09-28 0000877212 us-gaap:OperatingSegmentsMember zbra:AssetIntelligenceTrackingAITMember 2023-01-01 2023-09-30 0000877212 us-gaap:OperatingSegmentsMember zbra:EnterpriseVisibilityMobilityEVMMember 2024-06-30 2024-09-28 0000877212 us-gaap:OperatingSegmentsMember zbra:EnterpriseVisibilityMobilityEVMMember 2023-07-02 2023-09-30 0000877212 us-gaap:OperatingSegmentsMember zbra:EnterpriseVisibilityMobilityEVMMember 2024-01-01 2024-09-28 0000877212 us-gaap:OperatingSegmentsMember zbra:EnterpriseVisibilityMobilityEVMMember 2023-01-01 2023-09-30 0000877212 us-gaap:OperatingSegmentsMember 2024-06-30 2024-09-28 0000877212 us-gaap:OperatingSegmentsMember 2023-07-02 2023-09-30 0000877212 us-gaap:OperatingSegmentsMember 2024-01-01 2024-09-28 0000877212 us-gaap:OperatingSegmentsMember 2023-01-01 2023-09-30 0000877212 zbra:CorporateAndEliminationsMember 2024-06-30 2024-09-28 0000877212 zbra:CorporateAndEliminationsMember 2023-07-02 2023-09-30 0000877212 zbra:CorporateAndEliminationsMember 2024-01-01 2024-09-28 0000877212 zbra:CorporateAndEliminationsMember 2023-01-01 2023-09-30 0000877212 srt:NorthAmericaMember 2024-06-30 2024-09-28 0000877212 srt:NorthAmericaMember 2023-07-02 2023-09-30 0000877212 srt:NorthAmericaMember 2024-01-01 2024-09-28 0000877212 srt:NorthAmericaMember 2023-01-01 2023-09-30 0000877212 us-gaap:EMEAMember 2024-06-30 2024-09-28 0000877212 us-gaap:EMEAMember 2023-07-02 2023-09-30 0000877212 us-gaap:EMEAMember 2024-01-01 2024-09-28 0000877212 us-gaap:EMEAMember 2023-01-01 2023-09-30 0000877212 srt:AsiaPacificMember 2024-06-30 2024-09-28 0000877212 srt:AsiaPacificMember 2023-07-02 2023-09-30 0000877212 srt:AsiaPacificMember 2024-01-01 2024-09-28 0000877212 srt:AsiaPacificMember 2023-01-01 2023-09-30 0000877212 srt:LatinAmericaMember 2024-06-30 2024-09-28 0000877212 srt:LatinAmericaMember 2023-07-02 2023-09-30 0000877212 srt:LatinAmericaMember 2024-01-01 2024-09-28 0000877212 srt:LatinAmericaMember 2023-01-01 2023-09-30
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 28, 2024
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

| For the transition period from to

Commission File Number: 000-19406
Zebra Technologies Corporation
(Exact name of registrant as specified in its charter)

Delaware | 36-2675536
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)

3 Overlook Point, Lincolnshire, IL 60069
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (847) 634-6700
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of exchange on which registered
Class A Common Stock, par value $.01 per share |  | ZBRA |  | The NASDAQ Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large accelerated filer | ☒ | Accelerated filer | ☐
| Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  |  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of October 22, 2024, there were 51,580,028 shares of Class A Common Stock, $.01 par value, outstanding.

Table of Contents
ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
QUARTER ENDED SEPTEMBER 28, 2024
TABLE OF CONTENTS

|  | PAGE
PART I - FINANCIAL INFORMATION | 3
Item 1. | Consolidated Financial Statements | 3
| Consolidated Balance Sheets as of September 28, 2024 (unaudited) and December 31, 2023 | 3
| Consolidated Statements of Operations (unaudited) for the three and nine months ended September 28, 2024 and September 30, 2023 | 4
| Consolidated Statements of Comprehensive Income (unaudited) for the three and nine months ended September 28, 2024 and September 30, 2023 | 5
| Consolidated Statements of Stockholders’ Equity (unaudited) for the three and nine months ended September 28, 2024 and September 30, 2023 | 6
| Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 28, 2024 and September 30, 2023 | 8
| Notes to Consolidated Financial Statements (unaudited) | 8
| Note 1: Description of Business and Basis of Presentation | 9
| Note 2: Significant Accounting Policies | 9
| Note 3: Revenues | 10
| Note 4: Inventories | 11
| Note 5: Investments | 11
| Note 6: Exit and Restructuring Costs | 11
| Note 7: Fair Value Measurements | 11
| Note 8: Derivative Instruments | 13
| Note 9: Long-Term Debt | 15
| Note 10: Leases | 17
| Note 11: Accrued Liabilities, Commitments and Contingencies | 17
| Note 12: Income Taxes | 18
| Note 13: Earnings (Loss) Per Share | 18
| Note 14: Accumulated Other Comprehensive (Loss) Income | 19
| Note 15: Accounts Receivable Factoring | 19
| Note 16: Segment Information & Geographic Data | 20
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21
| Overview | 21
| Results of Operations | 22
| Results of Operations by Segment | 24
| Liquidity and Capital Resources | 26
| Significant Customers | 29
| Safe Harbor | 29
| New Accounting Pronouncements | 30
| Non-GAAP Measures | 30
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 30
Item 4. | Controls and Procedures | 30
Item 5. | Other Information | 34
PART II - OTHER INFORMATION | 31
Item 1. | Legal Proceedings | 31
Item 1A. | Risk Factors | 32
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 34
Item 6. | Exhibits | 35
Signatures | 36

2

Table of Contents
PART I - FINANCIAL INFORMATION

Item 1. | Consolidated Financial Statements

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except share data)

| September 28, 2024 |  | December 31, 2023
| (Unaudited) |  |
Assets |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 676 |  |  | $ | 137 |
Accounts receivable, net of allowances for doubtful accounts of $1 each as of September 28, 2024 and December 31, 2023 | 642 |  |  | 521 |
Inventories, net | 639 |  |  | 804 |
Income tax receivable | 67 |  |  | 63 |
Prepaid expenses and other current assets | 109 |  |  | 147 |
Total Current assets | 2,133 |  |  | 1,672 |
Property, plant and equipment, net | 302 |  |  | 309 |
Right-of-use lease assets | 173 |  |  | 169 |
Goodwill | 3,895 |  |  | 3,895 |
Other intangibles, net | 447 |  |  | 527 |
Deferred income taxes | 501 |  |  | 438 |
Other long-term assets | 239 |  |  | 296 |
Total Assets | $ | 7,690 |  |  | $ | 7,306 |
Liabilities and Stockholders’ Equity |  |  |
Current liabilities: |  |  |
Current portion of long-term debt | $ | 89 |  |  | $ | 173 |
Accounts payable | 533 |  |  | 456 |
Accrued liabilities | 490 |  |  | 504 |
Deferred revenue | 432 |  |  | 458 |
Income taxes payable | 18 |  |  | 7 |
Total Current liabilities | 1,562 |  |  | 1,598 |
Long-term debt | 2,080 |  |  | 2,047 |
Long-term lease liabilities | 162 |  |  | 152 |
Deferred income taxes | 66 |  |  | 67 |
Long-term deferred revenue | 304 |  |  | 312 |
Other long-term liabilities | 95 |  |  | 94 |
Total Liabilities | 4,269 |  |  | 4,270 |
Stockholders’ Equity: |  |  |
Preferred stock, $.01 par value; authorized 10,000,000 shares; none issued | — |  |  | — |
Class A common stock, $.01 par value; authorized 150,000,000 shares; issued 72,151,857 shares | 1 |  |  | 1 |
Additional paid-in capital | 653 |  |  | 615 |
Treasury stock at cost, 20,609,801 and 20,772,995 shares as of September 28, 2024 and December 31, 2023, respectively | (1,871) |  |  | (1,858) |
Retained earnings | 4,697 |  |  | 4,332 |
Accumulated other comprehensive loss | (59) |  |  | (54) |
Total Stockholders’ Equity | 3,421 |  |  | 3,036 |
Total Liabilities and Stockholders’ Equity | $ | 7,690 |  |  | $ | 7,306 |

See accompanying Notes to Consolidated Financial Statements.
3

Table of Contents
ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except share data)
(Unaudited)

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Net sales: |  |  |  |  |  |  |
Tangible products | $ | 1,019 |  |  | $ | 729 |  |  | $ | 2,931 |  |  | $ | 2,885 |
Services and software | 236 |  |  | 227 |  |  | 716 |  |  | 690 |
Total Net sales | 1,255 |  |  | 956 |  |  | 3,647 |  |  | 3,575 |
Cost of sales: |  |  |  |  |  |  |
Tangible products | 526 |  |  | 419 |  |  | 1,539 |  |  | 1,559 |
Services and software | 116 |  |  | 110 |  |  | 343 |  |  | 341 |
Total Cost of sales | 642 |  |  | 529 |  |  | 1,882 |  |  | 1,900 |
Gross profit | 613 |  |  | 427 |  |  | 1,765 |  |  | 1,675 |
Operating expenses: |  |  |  |  |  |  |
Selling and marketing | 151 |  |  | 138 |  |  | 449 |  |  | 445 |
Research and development | 141 |  |  | 127 |  |  | 425 |  |  | 403 |
General and administrative | 96 |  |  | 88 |  |  | 274 |  |  | 256 |
Amortization of intangible assets | 29 |  |  | 26 |  |  | 80 |  |  | 78 |
Acquisition and integration costs | 1 |  |  | 2 |  |  | 3 |  |  | 4 |
Exit and restructuring costs | 4 |  |  | 58 |  |  | 17 |  |  | 82 |
Total Operating expenses | 422 |  |  | 439 |  |  | 1,248 |  |  | 1,268 |
Operating income (loss) | 191 |  |  | (12) |  |  | 517 |  |  | 407 |
Other (loss) income, net: |  |  |  |  |  |  |
Foreign exchange (loss) gain | (9) |  |  | 6 |  |  | (6) |  |  | 2 |
Interest expense, net | (31) |  |  | (16) |  |  | (71) |  |  | (69) |
Other expense, net | (2) |  |  | (2) |  |  | (13) |  |  | (8) |
Total Other expense, net | (42) |  |  | (12) |  |  | (90) |  |  | (75) |
Income (loss) before income tax | 149 |  |  | (24) |  |  | 427 |  |  | 332 |
Income tax expense (benefit) | 12 |  |  | (9) |  |  | 62 |  |  | 53 |
Net income (loss) | $ | 137 |  |  | $ | (15) |  |  | $ | 365 |  |  | $ | 279 |
Basic earnings (loss) per share | $ | 2.65 |  |  | $ | (0.28) |  |  | $ | 7.09 |  |  | $ | 5.44 |
Diluted earnings (loss) per share | $ | 2.64 |  |  | $ | (0.28) |  |  | $ | 7.04 |  |  | $ | 5.40 |

See accompanying Notes to Consolidated Financial Statements.
4

Table of Contents
ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
(Unaudited)

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Net income (loss) | $ | 137 |  |  | $ | (15) |  |  | $ | 365 |  |  | $ | 279 |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |
Changes in unrealized (losses) gains on sales hedging | (16) |  |  | 23 |  |  | (6) |  |  | 24 |
Foreign currency translation adjustment | 9 |  |  | (7) |  |  | 1 |  |  | (2) |
Comprehensive income | $ | 130 |  |  | $ | 1 |  |  | $ | 360 |  |  | $ | 301 |

See accompanying Notes to Consolidated Financial Statements.
5

Table of Contents
ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In millions, except share data)
(Unaudited)

|  | Class A Common Stock Shares |  | Class A Common Stock Value |  | Additional Paid-in Capital |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Total
Balance at December 31, 2023 |  | 51,378,862 |  |  | $ | 1 |  |  | $ | 615 |  |  | $ | (1,858) |  |  | $ | 4,332 |  |  | $ | (54) |  |  | $ | 3,036 |
Issuances of treasury shares related to share-based compensation plans, net of forfeitures |  | 21,312 |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | — |  |  | (3) |
Shares withheld to fund withholding tax obligations related to share-based compensation plans |  | (206) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Share-based compensation |  | — |  |  | — |  |  | 17 |  |  | — |  |  | — |  |  | — |  |  | 17 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 115 |  |  | — |  |  | 115 |
Changes in unrealized gains and losses on sales hedging (net of income taxes) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 9 |  |  | 9 |
Foreign currency translation adjustment |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5) |  |  | (5) |
Balance at March 30, 2024 |  | 51,399,968 |  |  | $ | 1 |  |  | $ | 629 |  |  | $ | (1,858) |  |  | $ | 4,447 |  |  | $ | (50) |  |  | $ | 3,169 |
Issuances of treasury shares related to share-based compensation plans, net of forfeitures |  | 170,023 |  |  | — |  |  | (27) |  |  | 3 |  |  | — |  |  | — |  |  | (24) |
Share-based compensation |  | — |  |  | — |  |  | 31 |  |  | — |  |  | — |  |  | — |  |  | 31 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 113 |  |  | — |  |  | 113 |
Changes in unrealized gains and losses on sales hedging (net of income taxes) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | 1 |
Foreign currency translation adjustment |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3) |  |  | (3) |
Balance at June 29, 2024 |  | 51,569,991 |  |  | $ | 1 |  |  | $ | 633 |  |  | $ | (1,855) |  |  | $ | 4,560 |  |  | $ | (52) |  |  | $ | 3,287 |
Issuances of treasury shares related to share-based compensation plans, net of forfeitures |  | 22,369 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Share-based compensation |  | — |  |  | — |  |  | 20 |  |  | — |  |  | — |  |  | — |  |  | 20 |
Repurchase of common stock |  | (50,304) |  |  | — |  |  | — |  |  | (16) |  |  | — |  |  | — |  |  | (16) |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 137 |  |  | — |  |  | 137 |
Changes in unrealized gains and losses on sales hedging (net of income taxes) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (16) |  |  | (16) |
Foreign currency translation adjustment |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 9 |  |  | 9 |
Balance at September 28, 2024 |  | 51,542,056 |  |  | $ | 1 |  |  | $ | 653 |  |  | $ | (1,871) |  |  | $ | 4,697 |  |  | $ | (59) |  |  | $ | 3,421 |

=
6

Table of Contents

|  | Class A Common Stock Shares |  | Class A Common Stock Value |  | Additional Paid-in Capital |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Total
Balance at December 31, 2022 |  | 51,451,500 |  |  | $ | 1 |  |  | $ | 561 |  |  | $ | (1,799) |  |  | $ | 4,036 |  |  | $ | (66) |  |  | $ | 2,733 |
Issuances of treasury shares related to share-based compensation plans, net of forfeitures |  | 29,784 |  |  | — |  |  | 5 |  |  | — |  |  | — |  |  | — |  |  | 5 |
Shares withheld to fund withholding tax obligations related to share-based compensation plans |  | (504) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Share-based compensation |  | — |  |  | — |  |  | 18 |  |  | — |  |  | — |  |  | — |  |  | 18 |
Repurchase of common stock |  | (55,811) |  |  | — |  |  | — |  |  | (15) |  |  | — |  |  | — |  |  | (15) |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 150 |  |  | — |  |  | 150 |
Changes in unrealized gains and losses on sales hedging (net of income taxes) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3) |  |  | (3) |
Foreign currency translation adjustment |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3 |  |  | 3 |
Balance at April 1, 2023 |  | 51,424,969 |  |  | $ | 1 |  |  | $ | 584 |  |  | $ | (1,814) |  |  | $ | 4,186 |  |  | $ | (66) |  |  | $ | 2,891 |
Issuances of treasury shares related to share-based compensation plans, net of forfeitures |  | 75,271 |  |  | — |  |  | (6) |  |  | 1 |  |  | — |  |  | — |  |  | (5) |
Shares withheld to fund withholding tax obligations related to share-based compensation plans |  | (28,795) |  |  | — |  |  | — |  |  | (9) |  |  | — |  |  | — |  |  | (9) |
Share-based compensation |  | — |  |  | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | 2 |
Repurchase of common stock |  | (138,508) |  |  | — |  |  | — |  |  | (37) |  |  | — |  |  | — |  |  | (37) |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 144 |  |  | — |  |  | 144 |
Changes in unrealized gains and losses on sales hedging (net of income taxes) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4 |  |  | 4 |
Foreign currency translation adjustment |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | 2 |
Balance at July 1, 2023 |  | 51,332,937 |  |  | $ | 1 |  |  | $ | 580 |  |  | $ | (1,859) |  |  | $ | 4,330 |  |  | $ | (60) |  |  | $ | 2,992 |
Issuances of treasury shares related to share-based compensation plans, net of forfeitures |  | 26,506 |  |  | — |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | 1 |
Shares withheld to fund withholding tax obligations related to share-based compensation plans |  | (159) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Share-based compensation |  | — |  |  | — |  |  | 19 |  |  | — |  |  | — |  |  | — |  |  | 19 |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (15) |  |  | — |  |  | (15) |
Changes in unrealized gains and losses on sales hedging (net of income taxes) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 23 |  |  | 23 |
Foreign currency translation adjustment |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7) |  |  | (7) |
Balance at September 30, 2023 |  | 51,359,284 |  |  | $ | 1 |  |  | $ | 599 |  |  | $ | (1,858) |  |  | $ | 4,315 |  |  | $ | (44) |  |  | $ | 3,013 |

See accompanying Notes to Consolidated Financial Statements.
7

Table of Contents
ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)

| Nine Months Ended
| September 28, 2024 |  | September 30, 2023
Cash flows from operating activities: |  |  |
Net income | $ | 365 |  |  | $ | 279 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 130 |  |  | 132 |
Share-based compensation | 68 |  |  | 39 |
Deferred income taxes | (62) |  |  | (35) |
Unrealized gain on forward interest rate swaps | (31) |  |  | (34) |
Other, net | 12 |  |  | 3 |
Changes in operating assets and liabilities: |  |  |
Accounts receivable, net | (120) |  |  | 228 |
Inventories, net | 161 |  |  | 7 |
Other assets | 5 |  |  | (25) |
Accounts payable | 79 |  |  | (402) |
Accrued liabilities | 68 |  |  | (79) |
Deferred revenue | (34) |  |  | (12) |
Income taxes | 25 |  |  | (134) |
Settlement liability | (45) |  |  | (135) |
Cash receipts on forward interest rate swaps | 86 |  |  | 20 |
Other operating activities | — |  |  | 3 |
Net cash provided by (used in) operating activities | 707 |  |  | (145) |
Cash flows from investing activities: |  |  |
Purchases of property, plant and equipment | (41) |  |  | (48) |
Proceeds from sale of short-term investments | 2 |  |  | — |
Purchases of long-term investments | (3) |  |  | (1) |
Net cash used in investing activities | (42) |  |  | (49) |
Cash flows from financing activities: |  |  |
Payment of debt issuance costs, extinguishment costs and discounts | (9) |  |  | — |
Payments of debt | (694) |  |  | (221) |
Proceeds from issuance of debt | 651 |  |  | 469 |
Payments for repurchases of common stock | (16) |  |  | (52) |
Net payments related to share-based compensation plans | (27) |  |  | (8) |
Change in unremitted cash collections from servicing factored receivables | (35) |  |  | (48) |
Other financing activities | 3 |  |  | — |
Net cash (used in) provided by financing activities | (127) |  |  | 140 |
Effect of exchange rate changes on cash and cash equivalents, including restricted cash | — |  |  | (2) |
Net increase (decrease) in cash and cash equivalents, including restricted cash | 538 |  |  | (56) |
Cash and cash equivalents, including restricted cash, at beginning of period | 138 |  |  | 117 |
Cash and cash equivalents, including restricted cash, at end of period | $ | 676 |  |  | $ | 61 |
Less restricted cash, included in Prepaid expenses and other current assets | — |  |  | — |
Cash and cash equivalents at end of period | $ | 676 |  |  | $ | 61 |
Supplemental disclosures of cash flow information: |  |  |
Income taxes paid | $ | 90 |  |  | $ | 227 |
Interest paid inclusive of forward interest rate swaps | $ | 3 |  |  | $ | 80 |

Certain prior period amounts included in Net cash provided by (used in) operating activities have been reclassified to conform with the current period presentation.
See accompanying Notes to Consolidated Financial Statements.
8

Table of Contents
ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 Description of Business and Basis of Presentation
Zebra Technologies Corporation and its subsidiaries (“Zebra” or the “Company”) is a global leader providing innovative Enterprise Asset Intelligence (“EAI”) solutions in the automatic identification and data capture solutions industry. We design, manufacture, and sell a broad range of products and solutions, including cloud-based software subscriptions, that capture and move data. We also provide a full range of services, including maintenance, technical support, repair, managed and professional services. End-users of our products, solutions and services include those in retail and e-commerce, manufacturing, transportation and logistics, healthcare, public sector, and other industries. We provide our products, solutions and services globally through a direct sales force and an extensive network of channel partners.
Management prepared these unaudited interim consolidated financial statements according to the rules and regulations of the Securities and Exchange Commission for interim financial information and notes. As permitted under Article 10 of Regulation S-X and the instructions of Form 10-Q, these consolidated financial statements do not include all the information and notes required by United States Generally Accepted Accounting Principles (“GAAP”) for complete financial statements, although management believes that the disclosures made are adequate to make the information not misleading. These interim financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
In the opinion of the Company, these interim financial statements include all adjustments (of a normal, recurring nature) necessary to fairly present its Consolidated Balance Sheet as of September 28, 2024, the Consolidated Statements of Operations, Comprehensive Income and Stockholders’ Equity for the three and nine months ended September 28, 2024 and September 30, 2023, and the Consolidated Statement of Cash Flows for the nine months ended September 28, 2024 and September 30, 2023. These results, however, are not necessarily indicative of the results expected for the full fiscal year ending December 31, 2024.
Note 2 Significant Accounting Policies
For a discussion of our significant accounting policies, see Note 2, Significant Accounting Policies within Part II, Item 8. “Financial Statements and Supplementary Data” in the Annual Report on Form 10-K for the year ended December 31, 2023. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended December 31, 2023.
9

Table of Contents
Note 3 Revenues
The Company recognizes revenue to depict the transfer of goods, solutions or services to a customer at an amount that reflects the consideration which it expects to receive for providing those goods, solutions or services.
Revenues for tangible products are generally recognized upon shipment, whereas revenues for services and solution offerings are generally recognized over time by using an output or time-based method, assuming all other criteria for revenue recognition have been met. Revenues for software are recognized either upon delivery or over time using a time-based method, depending on how control is transferred to the customer. In cases where a bundle of products, services, solutions and/or software are delivered to the customer, judgment is required to select the method of progress which best reflects the transfer of control.
Disaggregation of Revenue
The following table presents our Net sales disaggregated by product category for each of our segments (in millions):

| Three Months Ended
| September 28, 2024 |  | September 30, 2023
Segment | Tangible Products |  | Services and Software |  | Total |  | Tangible Products |  | Services and Software |  | Total
AIT | $ | 382 |  |  | $ | 28 |  |  | $ | 410 |  |  | $ | 295 |  |  | $ | 29 |  |  | $ | 324 |
EVM | 637 |  |  | 208 |  |  | 845 |  |  | 434 |  |  | 198 |  |  | 632 |
Total | $ | 1,019 |  |  | $ | 236 |  |  | $ | 1,255 |  |  | $ | 729 |  |  | $ | 227 |  |  | $ | 956 |
| Nine Months Ended
| September 28, 2024 |  | September 30, 2023
Segment | Tangible Products |  | Services and Software |  | Total |  | Tangible Products |  | Services and Software |  | Total
AIT | $ | 1,115 |  |  | $ | 84 |  |  | $ | 1,199 |  |  | $ | 1,222 |  |  | $ | 83 |  |  | $ | 1,305 |
EVM | 1,816 |  |  | 632 |  |  | 2,448 |  |  | 1,663 |  |  | 607 |  |  | 2,270 |
Total | $ | 2,931 |  |  | $ | 716 |  |  | $ | 3,647 |  |  | $ | 2,885 |  |  | $ | 690 |  |  | $ | 3,575 |

In addition, refer to Note 16, Segment Information & Geographic Data for Net sales to customers by geographic region.
Performance Obligations
The Company’s remaining performance obligations relate to services and software solutions. The aggregated transaction price allocated to remaining performance obligations for arrangements with an original term exceeding one year was $1.24 billion and $1.13 billion, inclusive of deferred revenue, as of September 28, 2024 and December 31, 2023, respectively. On average, remaining performance obligations as of September 28, 2024 and December 31, 2023 are expected to be recognized over a period of approximately two years.
Contract Balances
Progress on satisfying performance obligations under contracts with customers related to billed revenues is reflected on the Consolidated Balance Sheets in Accounts receivable, net. Progress on satisfying performance obligations under contracts with customers related to unbilled revenues (“contract assets”) is reflected on the Consolidated Balance Sheets as Prepaid expenses and other current assets for revenues expected to be billed within the next twelve months, and Other long-term assets for revenues expected to be billed thereafter. The total contract asset balances were $13 million and $16 million as of September 28, 2024 and December 31, 2023, respectively. These contract assets result from timing differences between billing and satisfying performance obligations, as well as the impact from the allocation of the transaction price among performance obligations for contracts that include multiple performance obligations. Contract assets are evaluated for impairment and no impairment losses have been recognized during the three and nine months ended September 28, 2024 and September 30, 2023, respectively.
10

Table of Contents
Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $736 million and $770 million as of September 28, 2024 and December 31, 2023, respectively. During the three and nine months ended September 28, 2024, the Company recognized $107 million and $374 million in revenue, which was previously included in the beginning balance of deferred revenue as of December 31, 2023. During the three and nine months ended September 30, 2023, the Company recognized $100 million and $349 million in revenue, which was previously included in the beginning balance of deferred revenue as of December 31, 2022.
Note 4 Inventories
The categories of Inventories, net are as follows (in millions):

| September 28, 2024 |  | December 31, 2023
Raw materials (1) | $ | 270 |  |  | $ | 403 |
Work in process | 3 |  |  | 4 |
Finished goods | 366 |  |  | 397 |
Total Inventories, net | $ | 639 |  |  | $ | 804 |

(1) Raw material inventories primarily consist of product components as well as supplies used in repair operations.
Note 5 Investments
The carrying value of the Company’s long-term investments, which are included in Other long-term assets on the Consolidated Balance Sheets, was $110 million and $113 million as of September 28, 2024 and December 31, 2023.
During the nine months ended September 28, 2024 and September 30, 2023, the Company paid $3 million and $1 million, respectively, for the purchase of long-term investments. Net gains and losses related to the Company’s long-term investments are included within Other expense, net on the Consolidated Statements of Operations. There were no net gains or losses during the three months ended September 28, 2024. The Company recognized net losses of $6 million during the nine months ended September 28, 2024. Net gains and losses were not significant for the three and nine months ended September 30, 2023.
Note 6 Exit and Restructuring Costs
Total charges associated with the 2022 Productivity Plan, which was completed in the third quarter of 2024, and the U.S. voluntary retirement plan, which was completed in 2023, were $127 million incurred to date, including $4 million and $17 million recorded during the three and nine months ended September 28, 2024. The costs of these plans are classified within Exit and restructuring on the Consolidated Statements of Operations. The Company’s remaining payment obligations of $5 million, are reflected within Accrued liabilities on the Consolidated Balance Sheets.
The rollforward of the liability associated with Exit and restructuring activities is:

Balance as of December 31, 2023 | $ | 22 |
Exit and restructuring charges | 17
Non-cash utilization | (4)
Cash payments | (30)
Balance as of September 28, 2024 | $ | 5 |

Note 7 Fair Value Measurements
Financial assets and liabilities are measured using inputs from three levels of the fair value hierarchy in accordance with Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into the following three broad levels:
•Level 1: Quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs (e.g. U.S. Treasuries and money market funds).
11

Table of Contents
•Level 2: Observable prices that are based on inputs not quoted in active markets but corroborated by market data.
•Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs. In addition, the Company considers counterparty credit risk in the assessment of fair value.
The Company’s financial assets and liabilities carried at fair value as of September 28, 2024, are classified below (in millions):

| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Investments related to the deferred compensation plan | $ | 41 |  |  | $ | — |  |  | $ | — |  |  | $ | 41 |
Total Assets at fair value | $ | 41 |  |  | $ | — |  |  | $ | — |  |  | $ | 41 |
Liabilities: |  |  |  |  |  |  |
Foreign exchange contracts (1) | $ | 1 |  |  | $ | 14 |  |  | $ | — |  |  | $ | 15 |
Liabilities related to the deferred compensation plan | 41 |  |  | — |  |  | — |  |  | 41 |
Total Liabilities at fair value | $ | 42 |  |  | $ | 14 |  |  | $ | — |  |  | $ | 56 |

The Company’s financial assets and liabilities carried at fair value as of December 31, 2023, are classified below (in millions):

| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |
Forward interest rate swap contracts (2) | $ | — |  |  | $ | 83 |  |  | $ | — |  |  | $ | 83 |
Investments related to the deferred compensation plan | 41 |  |  | — |  |  | — |  |  | 41 |
Total Assets at fair value | $ | 41 |  |  | $ | 83 |  |  | $ | — |  |  | $ | 124 |
Liabilities: |  |  |  |  |  |  |
Foreign exchange contracts (1) | $ | 1 |  |  | $ | 6 |  |  | $ | — |  |  | $ | 7 |
Forward interest rate swap contracts (2) | — |  |  | 28 |  |  | — |  |  | 28 |
Liabilities related to the deferred compensation plan | 41 |  |  | — |  |  | — |  |  | 41 |
Total Liabilities at fair value | $ | 42 |  |  | $ | 34 |  |  | $ | — |  |  | $ | 76 |

(1)The fair value of the foreign exchange contracts is calculated as follows:
•Fair value of forward contracts associated with forecasted sales hedges is calculated using the period-end exchange rate adjusted for current forward points.
•Fair value of hedges against net assets denominated in foreign currencies is calculated at the period-end exchange rate adjusted for current forward points unless the hedge has been traded but not settled at period-end (Level 2). If this is the case, the fair value is calculated at the rate at which the hedge is being settled (Level 1).
(2)The fair value of forward interest rate swaps is based upon a valuation model that uses relevant observable market inputs at the quoted intervals, such as forward yield curves, and is adjusted for the Company’s credit risk and the interest rate swap terms.
12

Table of Contents
Note 8 Derivative Instruments
In the normal course of business, the Company is exposed to global market risks, including the effects of changes in foreign currency exchange rates and interest rates. The Company uses derivative instruments to manage its exposure to such risks and may elect to designate certain derivatives as hedging instruments under ASC Topic 815, Derivatives and Hedging (“ASC 815”). The Company formally documents all relationships between designated hedging instruments and hedged items as well as its risk management objectives and strategies for undertaking hedge transactions. The Company does not hold or issue derivatives for trading or speculative purposes.
In accordance with ASC 815, the Company recognizes derivative instruments as either assets or liabilities on the Consolidated Balance Sheets and measures them at fair value. The following table presents the fair value of its derivative instruments (in millions):

| Asset (Liability)
|  |  | Fair Values as of
| Balance Sheets Classification |  | September 28, 2024 |  | December 31, 2023
Derivative instruments designated as hedges: |  |  |  |  |
Foreign exchange contracts | Accrued liabilities |  | $ | (14) |  |  | $ | (6) |
Total derivative instruments designated as hedges |  |  | $ | (14) |  |  | $ | (6) |
Derivative instruments not designated as hedges: |  |  |  |  |
Forward interest rate swaps | Prepaid expenses and other current assets |  | $ | — |  |  | $ | 34 |
Forward interest rate swaps | Other long-term assets |  | — |  |  | 49 |
Foreign exchange contracts | Accrued liabilities |  | (1) |  |  | (1) |
Forward interest rate swaps | Accrued liabilities |  | — |  |  | (12) |
Forward interest rate swaps | Other long-term liabilities |  | — |  |  | (16) |
Total derivative instruments not designated as hedges |  |  | $ | (1) |  |  | $ | 54 |
Total net derivative (liability) asset |  |  | $ | (15) |  |  | $ | 48 |

The following table presents the net gains (losses) from changes in fair values of derivatives that are not designated as hedges (in millions):

| Gains (Losses) Recognized in Income
|  |  | Three Months Ended |  | Nine Months Ended
| Statements of Operations Classification |  | September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Derivative instruments not designated as hedges: |  |  |  |  |  |  |  |  |
Foreign exchange contracts | Foreign exchange (loss) gain |  | $ | (7) |  |  | $ | 1 |  |  | $ | (5) |  |  | $ | (3) |
Forward interest rate swaps | Interest expense, net |  | — |  |  | 23 |  |  | 31 |  |  | 34 |
Total net (loss) gain recognized in income |  |  | $ | (7) |  |  | $ | 24 |  |  | $ | 26 |  |  | $ | 31 |

Activities related to derivative instruments are reflected within Net cash provided by (used in) operating activities on the Consolidated Statements of Cash Flows.
Interest Rate Risk Management
The Company is exposed to market risk associated with interest rate payments on its borrowings under a term loan (“Term Loan A”), Revolving Credit Facility, and Receivables Financing Facilities, which bear interest at variable rates plus applicable margins. The Company manages its exposure to changes in interest rates by issuing both fixed and variable rate borrowings as well as periodically utilizing interest rate swaps to economically hedge interest rate exp osure based on current and projected market conditions.
13

Table of Contents
In the second quarter, the Company terminated all of its interest rate swap agreements, none of which were designated as hedges, resulting in a $77 million cash receipt that is classified within Cash flows from operating activities on the Consolidated Statements of Cash Flows. Total cash receipts for the nine months ended September 28, 2024 were $86 million. See Note 9, Long-Term Debt for further details related to the Company’s borrowings and interest rate exposure.
Credit and Market Risk Management
Financial instruments, including derivatives, expose the Company to counterparty credit risk of nonperformance and to market risk related to currency exchange rate and interest rate fluctuations. The Company manages its exposure to counterparty credit risk by establishing minimum credit standards, diversifying its counterparties, and monitoring its concentrations of credit. The Company’s counterparties are commercial banks with expertise in derivative financial instruments. The Company evaluates the impact of market risk on the fair value and cash flows of its derivative and other financial instruments by considering reasonably possible changes in interest rates and currency exchange rates. The Company continually monitors the creditworthiness of the customers to which it grants credit terms in the normal course of business. The terms and conditions of the Company’s credit policies are designed to mitigate concentrations of credit risk.
The Company’s master netting and other similar arrangements with the respective counterparties allow for net settlement under certain conditions, which are designed to reduce credit risk by permitting net settlement with the same counterparty. We present the assets and liabilities of our derivative financial instruments, for which we have net settlement agreements in place, on a net basis on the Consolidated Balance Sheets. If the derivative financial instruments had been presented gross on the Consolidated Balance Sheets, the asset and liability positions would have not been significant as of September 28, 2024 and December 31, 2023.
Foreign Currency Exchange Risk Management
The Company conducts business on a multinational basis in a variety of foreign currencies. Exposure to market risk for changes in foreign currency exchange rates arises primarily from Euro-denominated external revenues, cross-border financing activities between subsidiaries, and foreign currency denominated monetary assets and liabilities. The Company manages its objective of preserving the economic value of non-functional currency denominated cash flows by initially hedging transaction exposures with natural offsets and, once these opportunities have been exhausted, through foreign exchange forward and option contracts, as deemed appropriate.
The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) (“AOCI”) on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $2 million and $6 million of losses for the three months ended September 28, 2024 and September 30, 2023, respectively. Realized amounts reclassified to Net sales were $4 million of gains and $16 million of losses for the nine months ended September 28, 2024 and September 30, 2023, respectively. As of September 28, 2024 and December 31, 2023, the notional amounts of the Company’s foreign exchange cash flow hedges were €622 million and €485 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective.
The Company uses forward contracts, which are not designated as hedging instruments, to manage its exposures related to net assets denominated in foreign currencies. These forward contracts typically mature within one month after execution. Monetary gains and losses on these forward contracts are recorded in income and are generally offset by the transaction gains and losses related to their net asset positions. The notional values and the net fair values of these outstanding contracts were as follows (in millions):
14

Table of Contents

| September 28, 2024 |  | December 31, 2023
Notional balance of outstanding contracts: |  |  |
British Pound/U.S. Dollar | £ | 2 |  |  | £ | 11 |
Euro/U.S. Dollar | € | 183 |  |  | € | 80 |
Euro/Czech Koruna | € | 16 |  |  | € | 17 |
Japanese Yen/U.S. Dollar | ¥ | 274 |  |  | ¥ | 685 |
Singapore Dollar/U.S. Dollar | S$ | 19 |  |  | S$ | 14 |
Mexican Peso/U.S. Dollar | Mex$ | 166 |  |  | Mex$ | 144 |
Polish Zloty/U.S. Dollar | zł | 39 |  |  | zł | 116 |
Net fair value of liabilities of outstanding contracts | $ | 1 |  |  | $ | 1 |

Note 9 Long-Term Debt
The following table shows the carrying value of the Company’s debt (in millions):

| September 28, 2024 |  | December 31, 2023
Term Loan A | $ | 1,575 |  |  | $ | 1,684 |
Senior Notes | 500 |  |  | — |
Revolving Credit Facility | — |  |  | 413 |
Receivables Financing Facilities | 108 |  |  | 129 |
Total debt | $ | 2,183 |  |  | $ | 2,226 |
Less: Debt issuance costs | (11) |  |  | (2) |
Less: Unamortized discounts | (3) |  |  | (4) |
Less: Current portion of debt | (89) |  |  | (173) |
Total long-term debt | $ | 2,080 |  |  | $ | 2,047 |

As of September 28, 2024, the future maturities of debt are as follows (in millions):

2024 (3 months remaining) |  | $ | 89 |
2025 |  | — |
2026 |  | 88 |
2027 |  | 1,506 |
2028 |  | — |
Thereafter |  | 500 |
Total future maturities of debt |  | $ | 2,183 |

All borrowings as of September 28, 2024 were denominated in U.S. Dollars.
The estimated fair value of the Company’s debt approximated $2.2 billion as of both September 28, 2024 and December 31, 2023, respectively. These fair value amounts, developed based on inputs classified as Level 2 within the fair value hierarchy, represent the estimated value at which the Company’s lenders could trade its debt within the financial markets and do not represent the settlement value of these liabilities to the Company. The fair value of debt will continue to vary each period based on a number of factors, including fluctuations in market interest rates as well as changes to the Company’s credit ratings.
Term Loan A
The principal on Term Loan A is due in quarterly installments, with the next quarterly installment due in the second quarter of 2026 and the majority due upon maturity in 2027. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. As of September 28, 2024, the Term Loan A interest rate was 6.60%. Interest payments are made monthly and are subject to variable rates plus an applicable margin.
15

Table of Contents
Senior Notes
In the second quarter, the Company completed a private offering of $500 million senior unsecured notes (the “Senior Notes”) with a 6.5% fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company has the option or could be required to prepay certain outstanding amounts in the event of certain circumstances or transactions.
The Senior Notes are fully and unconditionally guaranteed on a senior unsecured basis by certain of Zebra’s existing and future subsidiaries. The Senior Notes contain covenants that, among other things, limit the ability of Zebra to: (i) grant or incur liens; (ii) have its subsidiaries guarantee debt without becoming guarantors; and (iii) merge or consolidate with another company or sell all or substantially all of its assets.
Revolving Credit Facility
The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of September 28, 2024, the Company had letters of credit totaling $10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $1,500 million to $1,490 million. As of September 28, 2024, the Revolving Credit Facility had an average interest rate of 6.19%. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027.
Receivables Financing Facility
As of September 28, 2024, the Company has a Receivables Financing Facility with a borrowing limit of up to $180 million. As collateral, the Company pledges perfected first-priority security interests in its U.S. domestically originated accounts receivable. The Company has accounted for transactions under this facility as secured borrowings. During the first quarter of 2024, the Company amended this facility to extend the maturity to March 19, 2027 but otherwise did not substantially change the terms of the facility.
As of September 28, 2024, the Company’s Consolidated Balance Sheets included $618 million of gross receivables that were pledged under the facility. As of September 28, 2024, $108 million had been borrowed, of which $89 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of September 28, 2024, the facility had an average interest rate of 5.89%. Interest is paid monthly on these borrowings.
The Company’s borrowings described above include terms and conditions that limit the incurrence of additional borrowings and require that certain financial ratios be maintained at designated levels.
As of September 28, 2024, the Company was in compliance with all debt covenants.
16

Table of Contents
Note 10 Leases
During the nine months ended September 28, 2024, the Company recorded $36 million of right-of-use (“ROU”) assets obtained in exchange for lease obligations primarily related to the extension of existing leases and the commencement of a new office facility lease.
Future minimum lease payments under non-cancellable leases as of September 28, 2024 were as follows (in millions):

2024 (3 months remaining) |  | $ | 16 |
2025 |  | 46 |
2026 |  | 39 |
2027 |  | 32 |
2028 |  | 30 |
Thereafter |  | 83 |
Total future minimum lease payments |  | $ | 246 |
Less: Interest |  | (44) |
Present value of lease liabilities |  | $ | 202 |
Reported as of September 28, 2024: |  |
Current portion of lease liabilities |  | $ | 40 |
Long-term lease liabilities |  | 162 |
Present value of lease liabilities |  | $ | 202 |

The current portion of lease liabilities is included within Accrued liabilities on the Consolidated Balance Sheets.
Note 11 Accrued Liabilities, Commitments and Contingencies
Accrued Liabilities
The components of Accrued liabilities are as follows (in millions):

| September 28, 2024 |  | December 31, 2023
Incentive compensation | $ | 134 |  |  | $ | 47 |
Unremitted cash collections due to banks on factored accounts receivable | 77 |  |  | 112 |
Payroll and benefits | 63 |  |  | 83 |
Customer rebates | 50 |  |  | 40 |
Current portion of lease liabilities | 40 |  |  | 42 |
Warranty | 26 |  |  | 27 |
Interest payable | 20 |  |  | 2 |
Freight and duty | 15 |  |  | 10 |
Exit and restructuring | 5 |  |  | 22 |
Settlement | — |  |  | 45 |
Other | 60 |  |  | 74 |
Accrued liabilities | $ | 490 |  |  | $ | 504 |

17

Table of Contents
Warranties
The following table is a summary of the Company’s accrued warranty obligations (in millions):

| Nine Months Ended
| September 28, 2024 |  | September 30, 2023
Balance at the beginning of the period | $ | 27 |  |  | $ | 26 |
Warranty expense | 19 |  |  | 21 |
Warranties fulfilled | (20) |  |  | (22) |
Balance at the end of the period | $ | 26 |  |  | $ | 25 |

Contingencies
The Company is subject to a variety of investigations, claims, suits, and other legal proceedings that arise from time to time in the ordinary course of business, including but not limited to, intellectual property, employment, tort, and breach of contract matters. The Company currently believes that the outcomes of such proceedings, individually and in the aggregate, will not have a material adverse impact on its business, cash flows, financial position, or results of operations. Any legal proceedings are subject to inherent uncertainties, and the Company’s view of these matters and their potential effects may change in the future. The Company records a liability for contingencies when a loss is deemed to be probable and the loss can be reasonably estimated.
Note 12 Income Taxes
The Company’s effective tax rate for the three and nine months ended September 28, 2024 was 8.1% and 14.5%, respectively, compared to 37.5% benefit and 16.0% expense for the three and nine months ended September 30, 2023. In the current periods, the variance from the 21% federal statutory rate was primarily due to the generation of tax credits and the favorable impacts of foreign earnings subject to U.S. taxation, offset partially by U.S. State income taxes and foreign rate differentials. In the prior periods, the difference was primarily due to a discrete tax benefit from the U.S. voluntary retirement plan, U.S. tax credits, and the favorable impacts of foreign earnings subject to U.S. taxation.
Note 13 Earnings (loss) Per Share
Basic net earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of diluted common shares outstanding. Diluted common shares outstanding is computed using the Treasury Stock method and, in periods of income, reflects the additional shares that would be outstanding if dilutive share-based compensation awards were converted into common shares during the period.
Earnings (loss) per share (in millions, except share data):

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Basic: |  |  |  |  |  |  |
Net income (loss) | $ | 137 |  |  | $ | (15) |  |  | $ | 365 |  |  | $ | 279 |
Weighted-average shares outstanding (1) | 51,567,216 |  |  | 51,336,645 |  |  | 51,480,812 |  |  | 51,380,876 |
Basic earnings (loss) per share | $ | 2.65 |  |  | $ | (0.28) |  |  | $ | 7.09 |  |  | $ | 5.44 |
Diluted: |  |  |  |  |  |  |
Net income (loss) | $ | 137 |  |  | $ | (15) |  |  | $ | 365 |  |  | $ | 279 |
Weighted-average shares outstanding (1) | 51,567,216 |  |  | 51,336,645 |  |  | 51,480,812 |  |  | 51,380,876 |
Dilutive shares (2) | 350,839 |  |  | — |  |  | 364,760 |  |  | 336,855 |
Diluted weighted-average shares outstanding | 51,918,055 |  |  | 51,336,645 |  |  | 51,845,572 |  |  | 51,717,731 |
Diluted earnings (loss) per share | $ | 2.64 |  |  | $ | (0.28) |  |  | $ | 7.04 |  |  | $ | 5.40 |

(1) In periods of a net loss, restricted stock and performance share awards, which are participating securities, are excluded from weighted-average shares outstanding.
18

Table of Contents
(2) In periods of a net loss, all unvested share-based awards are anti-dilutive and therefore excluded from diluted shares.
Anti-dilutive share-based compensation awards are excluded from diluted earnings (loss) per share calculations. There were 1,621 and 61,240 shares that were anti-dilutive for the three and nine months ended September 28, 2024, respectively. There were 446,331 and 250,025 shares that were anti-dilutive for the three and nine months ended September 30, 2023, respectively.
Note 14 Accumulated Other Comprehensive (Loss) Income
Stockholders’ equity includes certain items classified as AOCI, including:
•Unrealized gain (loss) on sales hedging which relates to derivative instruments used to hedge the exposure related to currency exchange rates for forecasted Euro sales. These hedges are designated as cash flow hedges, and the Company defers income statement recognition of gains and losses until the hedged transaction occurs. See Note 8, Derivative Instruments for more details.
•Foreign currency translation adjustments which relates to the Company’s non-U.S. subsidiary companies that have designated a functional currency other than the U.S. Dollar. The Company translates the subsidiary functional currency financial statements to U.S. Dollars using a combination of historical, period-end, and average foreign exchange rates. This combination of rates creates the foreign currency translation adjustment component of AOCI.
The changes in each component of AOCI during the nine months ended September 28, 2024 and September 30, 2023 were as follows (in millions):

|  | Unrealized gain (loss) on sales hedging |  |  |  | Foreign currency translation adjustments |  | Total
Balance at December 31, 2022 |  | $ | (11) |  |  |  |  | $ | (55) |  |  | $ | (66) |
Other comprehensive income (loss) before reclassifications |  | 16 |  |  |  |  | (2) |  |  | 14 |
Amounts reclassified from AOCI(1) |  | 16 |  |  |  |  | — |  |  | 16 |
Tax effect |  | (8) |  |  |  |  | — |  |  | (8) |
Other comprehensive income (loss), net of tax |  | 24 |  |  |  |  | (2) |  |  | 22 |
Balance at September 30, 2023 |  | $ | 13 |  |  |  |  | $ | (57) |  |  | $ | (44) |
Balance at December 31, 2023 |  | $ | (5) |  |  |  |  | $ | (49) |  |  | $ | (54) |
Other comprehensive income (loss) before reclassifications |  | (3) |  |  |  |  | 1 |  |  | (2) |
Amounts reclassified from AOCI(1) |  | (4) |  |  |  |  | — |  |  | (4) |
Tax effect |  | 1 |  |  |  |  | — |  |  | 1 |
Other comprehensive income (loss), net of tax |  | (6) |  |  |  |  | 1 |  |  | (5) |
Balance at September 28, 2024 |  | $ | (11) |  |  |  |  | $ | (48) |  |  | $ | (59) |

(1) See Note 8, Derivative Instruments regarding the timing of reclassifications to operating results.
Note 15 Accounts Receivable Factoring
The Company transfers certain receivables to banks without recourse as part of its credit and cash management activities. Such transfers are accounted for as sales and the related receivables are removed from the Company’s balance sheet. The Company does not maintain any beneficial interest in the receivables sold. The Company services the receivables on behalf of the banks, but otherwise maintains no significant continuing involvement with respect to the receivables. Sale proceeds that are representative of the fair value of factored receivables, less a factoring fee, are reflected in Cash flows from operating activities on the Consolidated Statements of Cash Flows, while sale proceeds in excess of the fair value of factored receivables are reflected in Cash flows from financing activities on the Consolidated Statements of Cash Flows.
The Company has a Receivables Factoring arrangement that was amended in the current quarter to limit the factoring of uncollected receivables originated from the EMEA and Asia-Pacific regions from €150 million to €75 million, which will revert to €150 million in the fourth quarter if not further amended. Otherwise, the amendment did not substantially change the terms
19

Table of Contents
of the arrangement. In the current quarter, the Company terminated its other arrangement, which allowed for the factoring of uncollected receivables originated from the EMEA region up to $50 million.
During the nine months ended September 28, 2024 and September 30, 2023, the Company received cash proceeds of $816 million and $1,077 million, respectively, from the sales of accounts receivables under its factoring arrangement. As of September 28, 2024 and December 31, 2023, there were a total of $7 million and $56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets.
As servicer of sold receivables, the Company had $77 million and $112 million of obligations that were not yet remitted to banks as of September 28, 2024 and December 31, 2023, respectively. These obligations are included within Accrued liabilities on the Consolidated Balance Sheets, with changes in such obligations reflected within Cash flows from financing activities on the Consolidated Statements of Cash Flows.
Note 16 Segment Information & Geographic Data
The Company’s operations consist of two reportable segments: Asset Intelligence & Tracking (“AIT”) and Enterprise Visibility & Mobility (“EVM”). The reportable segments have been identified based on the financial data utilized by the Company’s Chief Executive Officer (the chief operating decision maker or “CODM”) to assess segment performance and allocate resources among the Company’s segments. The CODM reviews adjusted operating income to assess segment profitability. To the extent applicable, segment operating income excludes business acquisition purchase accounting adjustments, amortization of intangible assets, acquisition and integration costs, impairment of goodwill and other intangibles, exit and restructuring costs, as well as certain other non-recurring costs. Segment assets are not reviewed by the Company’s CODM and therefore are not disclosed below.
Financial information by segment is presented as follows (in millions):

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Net sales: |  |  |  |  |  |  |
AIT | $ | 410 |  |  | $ | 324 |  |  | $ | 1,199 |  |  | $ | 1,305 |
EVM | 845 |  |  | 632 |  |  | 2,448 |  |  | 2,270 |
Total Net sales | $ | 1,255 |  |  | $ | 956 |  |  | $ | 3,647 |  |  | $ | 3,575 |
Operating income (loss): |  |  |  |  |  |  |
AIT(2) | $ | 83 |  |  | $ | 44 |  |  | $ | 232 |  |  | $ | 287 |
EVM(2) | 142 |  |  | 30 |  |  | 385 |  |  | 285 |
Total segment operating income | 225 |  |  | 74 |  |  | 617 |  |  | 572 |
Corporate (1) | (34) |  |  | (86) |  |  | (100) |  |  | (165) |
Total Operating income (loss) | $ | 191 |  |  | $ | (12) |  |  | $ | 517 |  |  | $ | 407 |

(1)To the extent applicable, amounts included in Corporate consist of business acquisition purchase accounting adjustments, amortization of intangible assets, acquisition and integration costs, impairment of goodwill and other intangibles, and exit and restructuring costs.
(2)AIT and EVM segment operating income includes depreciation and share-based compensation expense. The amounts of depreciation and share-based compensation expense are proportionate to each segment’s Net sales.
Information regarding the Company’s operations by geographic area is contained in the following tables. Net sales amounts are attributed to geographic area based on customer location.
20

Table of Contents
Net sales by region were as follows (in millions):

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
North America | $ | 628 |  |  | $ | 517 |  |  | $ | 1,839 |  |  | $ | 1,884 |
EMEA | 405 |  |  | 269 |  |  | 1,204 |  |  | 1,086 |
Asia-Pacific | 132 |  |  | 106 |  |  | 362 |  |  | 382 |
Latin America | 90 |  |  | 64 |  |  | 242 |  |  | 223 |
Total Net sales | $ | 1,255 |  |  | $ | 956 |  |  | $ | 3,647 |  |  | $ | 3,575 |

Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview
We are a global leader in the Automatic Identification and Data Capture (“AIDC”) industry. The AIDC market consists of mobile computing, data capture, radio frequency identification devices (“RFID”), barcode printing, and other workflow automation products and services. The Company’s solutions are proven to help our customers and end-users digitize and automate their workflows to achieve their critical business objectives, including improved productivity and operational efficiency, optimized regulatory compliance, and better customer experiences.
We design, manufacture, and sell a broad range of AIDC products, including: mobile computers, barcode scanners and imagers, RFID readers, specialty printers for barcode labeling and personal identification, real-time location systems (“RTLS”), related accessories and supplies, such as labels and other consumables, and related software applications. We also provide machine vision and robotics automation solutions; a full range of services, including maintenance, technical support, repair, managed and professional services; as well as cloud-based software subscriptions. End-users of our products, solutions and services include those in the retail and e-commerce, manufacturing, transportation and logistics, healthcare, public sector, and other industries within North America; Europe, Middle East, and Africa (“EMEA”); Asia Pacific; and Latin America.
We continue to advance our Enterprise Asset Intelligence (“EAI”) vision: every asset and front-line worker visible, connected, and fully optimized. Through continual innovation, we have expanded beyond the traditional AIDC market to transform activities such as factory production, packages moving through a supply chain, retail shopping, and the hospital patient journey. Data from enterprise assets, including status, condition, location, utilization, and preferences, is analyzed in the cloud to provide prioritized actionable insights. As a result, our solutions enable enterprises to “sense, analyze, and act” more effectively to optimize their activities.
The Company’s operations consist of two reportable segments that provide complementary offerings to our customers: Asset Intelligence & Tracking (“AIT”) and Enterprise Visibility & Mobility (“EVM”).
•The AIT segment is an industry leader in barcode printing and asset tracking technologies. Its major product lines include barcode and card printers, RFID and RTLS offerings, and supplies, including temperature-monitoring labels, and services.
•The EVM segment is an industry leader in automatic information and data capture solutions. Its major product lines include mobile computing, data capture, fixed industrial scanning and machine vision, services, and workflow optimization solutions. Our workflow optimization solutions include cloud-based software subscriptions, retail solutions, and robotic automation solutions.
We are a market leader in our core businesses, which are generally considered to be comprised of our mobile computing and data capture products, printing products and supplies, as well as support and repair services. We continue to focus on growth opportunities within adjacent and expansion markets by scaling and integrating our recent business acquisitions.
Third Quarter 2024 Financial Summary and Other Recent Developments
•Net sales were $1,255 million in the current quarter compared to $956 million in the prior year.
•Operating income was $191 million in the current quarter compared to an operating loss of $12 million in the prior year.
21

Table of Contents
•Net income was $137 million, or $2.64 per diluted share in the current quarter, compared to a net loss of $15 million, or $(0.28) per diluted share in the prior year.
•Net cash provided by operating activities was $707 million for the nine months ended September 28, 2024 as compared to net cash used in operating activities of $145 million for the nine months ended September 30, 2023.
In the current quarter, we saw the continuation of a modest recovery in demand trends that began to broaden across both of our segments. Our third quarter revenues and profitability improved from the first half of the year, and particularly as compared to the prior year which was negatively impacted by broad-based demand declines and distributor inventory reductions. We expect these trends to continue into the fourth quarter.
The Company completed its actions under the 2022 Productivity Plan in the third quarter. Total charges associated with the 2022 Productivity Plan and the U.S. voluntary retirement plan (“VRP”), which was completed in 2023, were $127 million, including $4 million recorded in the current quarter. The costs of these actions are classified within Exit and restructuring on the Consolidated Statements of Operations. Together, these programs have impacted over 9% of our global employee base and are expected to result in annualized net cost savings of approximately $120 million, primarily within Operating expenses. The Company has realized $110 million in net savings to date, with $50 million in 2023 and an incremental $60 million in the first nine months of 2024.
Results of Operations
Consolidated Results of Operations
(amounts in millions, except percentages)

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change |  | September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change
Net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tangible products | $ | 1,019 |  |  | $ | 729 |  |  | $ | 290 |  |  | 39.8 | % |  | $ | 2,931 |  |  | $ | 2,885 |  |  | $ | 46 |  |  | 1.6 | %
Services and software | 236 |  |  | 227 |  |  | 9 |  |  | 4.0 | % |  | 716 |  |  | 690 |  |  | 26 |  |  | 3.8 | %
Total Net sales | 1,255 |  |  | 956 |  |  | 299 |  |  | 31.3 | % |  | 3,647 |  |  | 3,575 |  |  | 72 |  |  | 2.0 | %
Gross profit | 613 |  |  | 427 |  |  | 186 |  |  | 43.6 | % |  | 1,765 |  |  | 1,675 |  |  | 90 |  |  | 5.4 | %
Gross margin | 48.8 | % |  | 44.7 | % |  |  |  | 410 bps |  | 48.4 | % |  | 46.9 | % |  |  |  | 150 bps
Operating expenses | 422 |  |  | 439 |  |  | (17) |  |  | (3.9) | % |  | 1,248 |  |  | 1,268 |  |  | (20) |  |  | (1.6) | %
Operating income (loss) | $ | 191 |  |  | $ | (12) |  |  | $ | 203 |  |  | 1,691.7 | % |  | $ | 517 |  |  | $ | 407 |  |  | $ | 110 |  |  | 27.0 | %

Net sales to customers by geographic region were as follows (amounts in millions, except percentages):

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change |  | September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change
North America | $ | 628 |  |  | $ | 517 |  |  | $ | 111 |  |  | 21.5 | % |  | $ | 1,839 |  |  | $ | 1,884 |  |  | $ | (45) |  |  | (2.4) | %
EMEA | 405 |  |  | 269 |  |  | 136 |  |  | 50.6 | % |  | 1,204 |  |  | 1,086 |  |  | 118 |  |  | 10.9 | %
Asia-Pacific | 132 |  |  | 106 |  |  | 26 |  |  | 24.5 | % |  | 362 |  |  | 382 |  |  | (20) |  |  | (5.2) | %
Latin America | 90 |  |  | 64 |  |  | 26 |  |  | 40.6 | % |  | 242 |  |  | 223 |  |  | 19 |  |  | 8.5 | %
Total Net sales | $ | 1,255 |  |  | $ | 956 |  |  | $ | 299 |  |  | 31.3 | % |  | $ | 3,647 |  |  | $ | 3,575 |  |  | $ | 72 |  |  | 2.0 | %

22

Table of Contents
Operating expenses are summarized below (amounts in millions, except percentages):

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | As a % of Net sales |  | September 28, 2024 |  | September 30, 2023 |  | As a % of Net sales
|  | 2024 |  | 2023 |  |  |  | 2024 |  | 2023
Selling and marketing | $ | 151 |  |  | $ | 138 |  |  | 12.0 | % |  | 14.4 | % |  | $ | 449 |  |  | $ | 445 |  |  | 12.3 | % |  | 12.4 | %
Research and development | 141 |  |  | 127 |  |  | 11.2 | % |  | 13.3 | % |  | 425 |  |  | 403 |  |  | 11.7 | % |  | 11.3 | %
General and administrative | 96 |  |  | 88 |  |  | 7.6 | % |  | 9.2 | % |  | 274 |  |  | 256 |  |  | 7.5 | % |  | 7.2 | %
Amortization of intangible assets | 29 |  |  | 26 |  |  | NM |  | NM |  | 80 |  |  | 78 |  |  | NM |  | NM
Acquisition and integration costs | 1 |  |  | 2 |  |  | NM |  | NM |  | 3 |  |  | 4 |  |  | NM |  | NM
Exit and restructuring costs | 4 |  |  | 58 |  |  | NM |  | NM |  | 17 |  |  | 82 |  |  | NM |  | NM
Total Operating expenses | $ | 422 |  |  | $ | 439 |  |  | 33.6 | % |  | 45.9 | % |  | $ | 1,248 |  |  | $ | 1,268 |  |  | 34.2 | % |  | 35.5 | %

Consolidated Organic Net sales growth:

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 28, 2024
Reported GAAP Consolidated Net sales growth | 31.3 | % |  | 2.0 | %
Adjustments: |  |  |
Impact of foreign currency translations (1) | (0.7) | % |  | (0.5) | %
Consolidated Organic Net sales growth (2) | 30.6 | % |  | 1.5 | %

(1)Operating results reported in U.S. Dollars are affected by foreign currency exchange rate fluctuations. Foreign currency translation impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. Dollar. This impact is calculated by translating the current period results at the currency exchange rates used in the comparable prior year period, inclusive of the Company’s foreign currency hedging program.
(2)Consolidated Organic Net sales growth is a non-GAAP financial measure. See the Non-GAAP Measures section at the end of this item.
Third quarter 2024 compared to third quarter 2023
Total Net sales increased by $299 million or 31.3% compared to the prior year reflecting growth in both of our segments. The prior year period was negatively impacted by declines in broad-based demand and actions taken by distributors to reduce their on-hand inventory levels. Excluding the effects of currency changes, Consolidated Organic Net sales increased by 30.6%.
Gross margin increased to 48.8% for the current year compared to 44.7% for the prior year. As compared to the prior year, Gross margin was higher in both of our segments which benefited from volume leverage in the current year.
Operating expenses for the quarters ended September 28, 2024 and September 30, 2023 were $422 million and $439 million, or 33.6% and 45.9% of Net sales, respectively. Current year Operating expenses were lower than the prior year primarily due to lower Exit and restructuring costs and incremental savings largely attributed to our Exit and restructuring actions, partially offset by higher incentive compensation. The decrease as a percentage of Net sales compared to the prior year reflects the impact of expense leveraging.
Operating income was $191 million for the current year compared to an operating loss of $12 million in the prior year. The increase was due to higher Gross profit and lower Operating expenses.
Net income increased compared to the prior year primarily due to higher Operating income, as described above, partially offset by higher Other expense, net. The increase in Other expense, net was primarily due to interest rate swap gains in the prior year and unfavorable changes in Foreign exchange (loss) gain as compared to the prior year.
23

Table of Contents
The Company’s effective tax rates for the three months ended September 28, 2024 and September 30, 2023 were 8.1% expense and 37.5% benefit, respectively. The change in the effective tax rates year over year was primarily due to increased foreign income taxed favorably in the U.S. for the current year, while the prior year included a discrete tax benefit related to the VRP.
Diluted earnings per share increased to $2.64 as compared to $(0.28) in the prior year due to higher Net income.
Year to date 2024 compared to Year to date 2023
Total Net sales increased $72 million or 2.0% compared to the prior year reflecting growth in our EVM segment that was largely offset by a decline in our AIT segment as the recovery in demand trends benefited EVM earlier in the current year than AIT. Excluding the effects of currency changes, Consolidated Organic Net sales increased by 1.5%.
Gross margin increased to 48.4% for the current year compared to 46.9% for the prior year. As compared to the prior year, Gross margin was higher in our EVM segment and lower in our AIT segment.
Operating expenses for the nine months ended September 28, 2024 and September 30, 2023 were $1,248 million and $1,268 million, or 34.2% and 35.5% of Net sales, respectively. Current year Operating expenses were lower than the prior year primarily due to lower Exit and restructuring costs and incremental savings largely attributed to our Exit and restructuring actions, partially offset by higher incentive compensation.
Operating income was $517 million for the current year compared to $407 million in the prior year. The increase was due to higher Gross profit and lower Operating expenses.
Net income increased compared to the prior year primarily due to higher Operating income, as described above, partially offset by higher Other expense, net. The increase in Other expense, net was primarily due to unfavorable changes in Foreign exchange (loss) gain as compared to the prior year and a long-term investment loss in the current year.
The Company’s effective tax rates for the nine months ended September 28, 2024 and September 30, 2023 were 14.5% and 16.0%, respectively.
Diluted earnings per share increased to $7.04 as compared to $5.40 in the prior year due to higher Net income.
Results of Operations by Segment
The following commentary should be read in conjunction with the financial results of each reportable business segment as detailed in Note 16, Segment Information & Geographic Data in the Notes to Consolidated Financial Statements. To the extent applicable, segment operating income excludes business acquisition purchase accounting adjustments, amortization of intangible assets, acquisition and integration costs, impairment of goodwill and other intangibles, exit and restructuring costs, as well as certain other non-recurring costs.
Asset Intelligence & Tracking Segment (“AIT”)
(amounts in millions, except percentages)

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change |  | September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change
Net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tangible products | $ | 382 |  |  | $ | 295 |  |  | $ | 87 |  |  | 29.5 | % |  | $ | 1,115 |  |  | $ | 1,222 |  |  | $ | (107) |  |  | (8.8) | %
Services and software | 28 |  |  | 29 |  |  | (1) |  |  | (3.4) | % |  | 84 |  |  | 83 |  |  | 1 |  |  | 1.2 | %
Total Net sales | 410 |  |  | 324 |  |  | 86 |  |  | 26.5 | % |  | 1,199 |  |  | 1,305 |  |  | (106) |  |  | (8.1) | %
Gross profit | 199 |  |  | 145 |  |  | 54 |  |  | 37.2 | % |  | 570 |  |  | 628 |  |  | (58) |  |  | (9.2) | %
Gross margin | 48.5 | % |  | 44.8 | % |  |  |  | 370 bps |  | 47.5 | % |  | 48.1 | % |  |  |  | (60) bps
Operating expenses | 116 |  |  | 101 |  |  | 15 |  |  | 14.9 | % |  | 338 |  |  | 341 |  |  | (3) |  |  | (0.9) | %
Operating income | $ | 83 |  |  | $ | 44 |  |  | $ | 39 |  |  | 88.6 | % |  | $ | 232 |  |  | $ | 287 |  |  | $ | (55) |  |  | (19.2) | %

AIT Organic Net sales growth (decline):
24

Table of Contents

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 28, 2024
AIT Reported GAAP Net sales growth (decline) | 26.5 | % |  | (8.1) | %
Adjustments: |  |  |
Impact of foreign currency translations (1) | (0.7) | % |  | (0.6) | %
AIT Organic Net sales growth (decline) (2) | 25.8 | % |  | (8.7) | %

(1)Operating results reported in U.S. Dollars are affected by foreign currency exchange rate fluctuations. Foreign currency translation impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. Dollar. This impact is calculated by translating the current period results at the currency exchange rates used in the comparable prior year period, inclusive of the Company’s foreign currency hedging program.
(2)AIT Organic Net sales growth (decline) is a non-GAAP financial measure. See the Non-GAAP Measures section at the end of this item.
Third quarter 2024 compared to third quarter 2023
Total Net sales for AIT increased $86 million or 26.5% compared to the prior year primarily due to higher sales of printing products (contributing the majority of the total increase) and RFID products. Excluding the impact of foreign currency changes, AIT Organic Net sales increased by 25.8%.
Gross margin increased to 48.5% in the current year compared to 44.8% for the prior year primarily due to favorable business mix and volume leverage, partially offset by higher freight rates.
Operating income increased 88.6% in the current year compared to the prior year due to higher Gross profit, partially offset by higher Operating expenses.
Year to date 2024 compared to Year to date 2023
Total Net sales for AIT decreased $106 million or 8.1% compared to the prior year primarily due to lower sales of printing products. Excluding the impact of foreign currency changes, AIT Organic Net sales decreased by 8.7%.
Gross margin decreased to 47.5% in the current year compared to 48.1% for the prior year primarily due to volume deleveraging, higher inventory-related charges, and unfavorable business mix.
Operating income decreased 19.2% in the current year compared to the prior year primarily due to lower Gross profit.
Enterprise Visibility & Mobility Segment (“EVM”)
(amounts in millions, except percentages)

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change |  | September 28, 2024 |  | September 30, 2023 |  | $ Change |  | % Change
Net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tangible products | $ | 637 |  |  | $ | 434 |  |  | $ | 203 |  |  | 46.8 | % |  | $ | 1,816 |  |  | $ | 1,663 |  |  | $ | 153 |  |  | 9.2 | %
Services and software | 208 |  |  | 198 |  |  | 10 |  |  | 5.1 | % |  | 632 |  |  | 607 |  |  | 25 |  |  | 4.1 | %
Total Net sales | 845 |  |  | 632 |  |  | 213 |  |  | 33.7 | % |  | 2,448 |  |  | 2,270 |  |  | 178 |  |  | 7.8 | %
Gross profit | 414 |  |  | 282 |  |  | 132 |  |  | 46.8 | % |  | 1,195 |  |  | 1,047 |  |  | 148 |  |  | 14.1 | %
Gross margin | 49.0 | % |  | 44.6 | % |  |  |  | 440 bps |  | 48.8 | % |  | 46.1 | % |  |  |  | 270 bps
Operating expenses | 272 |  |  | 252 |  |  | 20 |  |  | 7.9 | % |  | 810 |  |  | 762 |  |  | 48 |  |  | 6.3 | %
Operating income | $ | 142 |  |  | $ | 30 |  |  | $ | 112 |  |  | 373.3 | % |  | $ | 385 |  |  | $ | 285 |  |  | $ | 100 |  |  | 35.1 | %

25

Table of Contents
EVM Organic Net sales growth:

| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 28, 2024
EVM Reported GAAP Net sales growth | 33.7 | % |  | 7.8 | %
Adjustments: |  |  |
Impact of foreign currency translations (1) | (0.7) | % |  | (0.4) | %
EVM Organic Net sales growth (2) | 33.0 | % |  | 7.4 | %

(1)Operating results reported in U.S. Dollars are affected by foreign currency exchange rate fluctuations. Foreign currency translation impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. Dollar. This impact is calculated by translating the current period results at the currency exchange rates used in the comparable prior year period, inclusive of the Company’s foreign currency hedging program.
(2)EVM Organic Net sales growth is a non-GAAP financial measure. See the Non-GAAP Measures section at the end of this item.
Third quarter 2024 compared to third quarter 2023
Total Net sales for EVM increased $213 million or 33.7% compared to the prior year primarily due to higher sales of mobile computing (contributing the majority of the total increase) and data capture products. Excluding the impacts of foreign currency changes, EVM Organic Net sales increased by 33.0%.
Gross margin increased to 49.0% in the current year compared to 44.6% for the prior year primarily due to volume leverage, lower inventory-related charges, and favorable business mix.
Operating income for the current year increased by 373.3% compared to the prior year due to higher Gross profit, partially offset by higher Operating expenses.
Year to date 2024 compared to Year to date 2023
Total Net sales for EVM increased $178 million or 7.8% compared to the prior year primarily due to higher sales of mobile computing products, and services and software, partially offset by lower sales of data capture products. Excluding the impacts of foreign currency changes, EVM Organic Net sales increased by 7.4%.
Gross margin increased to 48.8% in the current year compared to 46.1% for the prior year primarily due to primarily due to favorable business mix and higher service and software margins, volume leverage, lower inventory-related charges, and lower freight rates.
Operating income for the current year increased by 35.1% compared to the prior year due to higher Gross profit, partially offset by higher Operating expenses.
Liquidity and Capital Resources
The primary factors that influence our liquidity include the amount and timing of cash collections from our customers, cash payments to our suppliers, capital expenditures, acquisitions, and share repurchases. Management believes that our existing capital resources, inclusive of available borrowing capacity on debt and other financing facilities and funds generated from operations, are sufficient to meet anticipated capital requirements and service our indebtedness. The following table summarizes our cash flow activities for the periods indicated (in millions):
26

Table of Contents

| Nine Months Ended
Cash flow provided by (used in): | September 28, 2024 |  | September 30, 2023 |  | $ Change
Operating activities | $ | 707 |  |  | $ | (145) |  |  | $ | 852 |
Investing activities | (42) |  |  | (49) |  |  | 7 |
Financing activities | (127) |  |  | 140 |  |  | (267) |
Effect of exchange rates on cash balances | — |  |  | (2) |  |  | 2 |
Net change in cash and cash equivalents, including restricted cash | $ | 538 |  |  | $ | (56) |  |  | $ | 594 |

The change in our cash and cash equivalents balance during the nine months ended September 28, 2024 compared to the prior year is primarily due to the following:
•$852 million change in operating activities primarily due to lower cash payments for inventory purchases and the reduction of overall inventory levels, lower income tax, legal settlement, and employee incentive compensation payments, higher cash receipts on interest rate swaps attributed to the termination of those agreements, as well as overall improved operating profits.
•$267 million change in financing activities primarily due to current year net debt repayments as a portion of the recently issued Senior Notes was utilized to reduce total debt, compared to net borrowings in the prior year.
Company Debt
The following table shows the carrying value of the Company’s debt (in millions):

| September 28, 2024 |  | December 31, 2023
Term Loan A | $ | 1,575 |  |  | $ | 1,684 |
Senior Notes | 500 |  |  | — |
Revolving Credit Facility | — |  |  | 413 |
Receivables Financing Facilities | 108 |  |  | 129 |
Total debt | $ | 2,183 |  |  | $ | 2,226 |
Less: Debt issuance costs | (11) |  |  | (2) |
Less: Unamortized discounts | (3) |  |  | (4) |
Less: Current portion of debt | (89) |  |  | (173) |
Total long-term debt | $ | 2,080 |  |  | $ | 2,047 |

Term Loan A
The principal on Term Loan A is due in quarterly installments, with the next quarterly installment due in the second quarter of 2026 and the majority due upon maturity in 2027. The Company may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. As of September 28, 2024, the Term Loan A interest rate was 6.60%. Interest payments are made monthly and are subject to variable rates plus an applicable margin.
Senior Notes
In the second quarter, the Company completed a private offering of $500 million senior unsecured notes (the “Senior Notes”) with a 6.5% fixed interest rate. The net proceeds of the issuance, after deducting debt issuance costs which were deferred, were approximately $492 million. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year, commencing on December 1, 2024. The Company has the option or could be required to prepay certain outstanding amounts in the event of certain circumstances or transactions.
The Senior Notes are fully and unconditionally guaranteed on a senior unsecured basis by certain of Zebra’s existing and future subsidiaries. The Senior Notes contain covenants that, among other things, limit the ability of Zebra to: (i) grant or incur liens; (ii) have its subsidiaries guarantee debt without becoming guarantors; and (iii) merge or consolidate with another company or sell all or substantially all of its assets.
27

Table of Contents
Revolving Credit Facility
The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of September 28, 2024, the Company had letters of credit totaling $10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $1,500 million to $1,490 million. As of September 28, 2024, the Revolving Credit Facility had an average interest rate of 6.19%. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027.
Receivables Financing Facility
As of September 28, 2024, the Company has a Receivables Financing Facility with a borrowing limit of up to $180 million. As collateral, the Company pledges perfected first-priority security interests in its U.S. domestically originated accounts receivable. The Company has accounted for transactions under this facility as secured borrowings. During the first quarter of 2024, the Company amended this facility to extend the maturity to March 19, 2027 but otherwise did not substantially change the terms of the facility.
As of September 28, 2024, the Company’s Consolidated Balance Sheets included $618 million of gross receivables that were pledged under the facility. As of September 28, 2024, $108 million had been borrowed, of which $89 million was classified as current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of September 28, 2024, the facility had an average interest rate of 5.89%. Interest is paid monthly on these borrowings.
See Note 9, Long-Term Debt in the Notes to Consolidated Financial Statements for further details related to the Company’s debt instruments.
Receivables Factoring
The Company transfers certain receivables to banks without recourse as part of its credit and cash management activities. Such transfers are accounted for as sales and the related receivables are removed from the Company’s balance sheet. The Company does not maintain any beneficial interest in the receivables sold. The Company services the receivables on behalf of the banks, but otherwise maintains no significant continuing involvement with respect to the receivables. Sale proceeds that are representative of the fair value of factored receivables, less a factoring fee, are reflected in Cash flows from operating activities on the Consolidated Statements of Cash Flows, while sale proceeds in excess of the fair value of factored receivables are reflected in Cash flows from financing activities on the Consolidated Statements of Cash Flows.
As of September 28, 2024 and December 31, 2023, there were a total of $7 million and $56 million, respectively, of uncollected receivables that had been sold and removed from the Company’s Consolidated Balance Sheets.
As servicer of sold receivables, the Company had $77 million and $112 million of obligations that were not yet remitted to banks as of September 28, 2024 and December 31, 2023, respectively. These obligations are included within Accrued liabilities on the Consolidated Balance Sheets, with changes in such obligations reflected within Cash flows from financing activities on the Consolidated Statements of Cash Flows.
See Note 15, Accounts Receivable Factoring in the Notes to Consolidated Financial Statements for further details.
Share Repurchases
On May 17, 2022, the Company announced that its Board of Directors authorized a share repurchase program for up to an incremental $1 billion of its outstanding shares of common stock. This authorization augments the previous $1 billion share repurchase authorization which was announced on July 30, 2019. The May 2022 share repurchase program does not have a stated expiration date. In the fourth quarter of 2022, the Company completed its original authorization of $1 billion in share repurchases. The level of the Company’s repurchases depends on a number of factors, including its financial condition, capital requirements, cash flows, results of operations, future business prospects and other factors its management may deem relevant. The timing, volume, and nature of repurchases are subject to market conditions, applicable securities laws and other factors and may be amended, suspended or discontinued at any time. Repurchases may be affected from time to time through open market purchases, including pursuant to a pre-set trading plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. During the first nine months of 2024, the Company repurchased 50,304 shares of common stock for approximately $16 million. As of September 28, 2024, the Company has cumulatively repurchased 459,318 shares of common stock for approximately $123 million, resulting in a remaining amount of share repurchases authorized under the May 2022 program of $877 million.
28

Table of Contents
Significant Customers
End-users of our products, solutions and services are diversified across a wide variety of industries. We have three customers, who are distributors of the Company’s products and solutions, that individually accounted for more than 10% of our Net sales for the periods presented. In the aggregate, the approximate percentage of our segment and Company total Net sales was as follows:

| Nine Months Ended
| September 28, 2024 |  | September 30, 2023
| AIT |  | EVM |  | Total |  | AIT |  | EVM |  | Total
Significant customers as a % of Net sales | 18 | % |  | 38 | % |  | 56 | % |  | 18 | % |  | 27 | % |  | 45 | %

These customers accounted for 56% of accounts receivable as of September 28, 2024. No other customer accounted for more than 10% of total Net sales during the period ended September 28, 2024.
Safe Harbor
Forward-looking statements contained in this filing are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995 and are highly dependent upon a variety of important factors, which could cause actual results to differ materially from those expressed or implied in such forward-looking statements. When used in this document and documents referenced, the words “anticipate,” “believe,” “intend,” “estimate,” “will,” and “expect” and similar expressions as they relate to the Company or its management are intended to identify such forward-looking statements but are not the exclusive means of identifying these statements. The forward-looking statements include, but are not limited to, the Company’s financial outlook for full year of 2024. These forward-looking statements are based on current expectations, forecasts and assumptions, and are subject to the risks and uncertainties inherent in the Company’s industry, market conditions, general domestic and international economic conditions, and other factors. These factors include:
•Market acceptance of the Company’s products, services and solution offerings and competitors’ offerings and the potential effects of emerging technologies and changes in customer requirements,
•The effect of global market conditions, including the North America; EMEA; Latin America; and Asia-Pacific regions in which we do business,
•The impact of changes in foreign exchange rates, customs duties and trade policies due to the large percentage of our sales and operations being outside the U.S.,
•Our ability to control manufacturing and operating costs,
•Risks related to the manufacturing of the Company’s products and conducting business operations in non-U.S. countries, including the risk of depending on key suppliers who are also in non-U.S. countries,
•The Company’s ability to purchase sufficient materials, parts, and components, our ability to provide services, software, and products to meet customer demand, particularly in light of global economic conditions,
•The availability of credit and the volatility of capital markets, which may affect our suppliers, customers, and ourselves,
•Success of integrating acquisitions,
•Our ability to attract, retain, develop, and motivate key personnel,
•Interest rate and financial market conditions,
•Access to cash and cash equivalents held outside the U.S.,
•The effect of natural disasters, man-made disasters, public health issues (including pandemics), and cybersecurity incidents on our business,
•The impact of changes in foreign and domestic governmental policies, laws, or regulations,
•The outcome of litigation in which the Company may be involved, particularly litigation or claims related to infringement of third-party intellectual property rights, and
•The outcome of any future tax matters or tax law changes.
We encourage readers of this report to review Part II, Item 1A, “Risk Factors” in this report for further discussion of issues that could affect the Company’s future results. We undertake no obligation, other than as may be required by law, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances, or any other reason after the date of this report.
29

Table of Contents
New Accounting Pronouncements
We do not expect any recently issued accounting pronouncements to have a material impact on our consolidated financial statements.
Non-GAAP Measures
The Company has provided reconciliations of the supplemental non-GAAP financial measures, as defined under the rules of the Securities and Exchange Commission, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP.
These supplemental non-GAAP financial measures – Consolidated Organic Net sales growth, AIT Organic Net sales growth (decline), and EVM Organic Net sales growth – are presented because our management evaluates our financial results both including and excluding the effects of business acquisitions and foreign currency translation, as applicable. Management believes that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of our business from period to period and trends in our historical operating results. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for, or as an alternative to, and should be considered in conjunction with the GAAP financial measures presented.

Item 3. | Quantitative and Qualitative Disclosures About Market Risk

There were no material changes in the Company’s market risk during the quarter ended September 28, 2024. For additional information on market risk, refer to Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in the Annual Report on Form 10-K for the year ended December 31, 2023.

Item 4. | Controls and Procedures

Management’s Report on Disclosure Controls
Our management is responsible for establishing and maintaining adequate disclosure controls as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management assessed the effectiveness of our disclosure controls as of September 28, 2024. Based on this assessment and those criteria, our management believes that, as of September 28, 2024, our disclosure controls were effective.
Changes in Internal Control over Financial Reporting
During the quarter ended September 28, 2024, there have been no changes in our internal controls that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on the Effectiveness of Controls
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within Zebra have been prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
30

Table of Contents
PART II - OTHER INFORMATION

Item 1. | Legal Proceedings

See Note 11, Accrued Liabilities, Commitments and Contingencies in the Notes to Consolidated Financial Statements included in this report.
31

Table of Contents

Item 1A. | Risk Factors

In addition to the other information included in this report, you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in the Annual Report on Form 10-K for the year ended December 31, 2023, and the factors identified under “Safe Harbor” in Part I, Item 2 of this Quarterly Report on Form 10-Q, which could materially affect our business, financial condition, cash flows, or results of operations. The risks described in the Annual Report are not the only risks facing the Company. Additional risks and uncertainties not currently known to the Company or that the Company currently considers immaterial also may materially adversely affect its business, financial condition, and/or operating results. There have been no material changes to the risk factors included in our Annual Report for the year ended December 31, 2023, other than as described below.
Our indebtedness could adversely affect our business. Our indebtedness could have important consequences, including the following:
• We may experience difficulty in satisfying our obligations with respect to our existing indebtedness or future indebtedness;
• Our ability to obtain additional financing for working capital, capital expenditures, acquisitions, or general corporate purposes may be impaired;
• We may be unable to create liens on certain assets to secure debt;
• Our subsidiary guarantors may not have sufficient assets or cash flow to allow them to guarantee new debt and existing debt;
• We may be at a competitive disadvantage with reduced flexibility in planning for, or responding to, changing conditions in the industry, including increased competition; and
• We may be more vulnerable to economic downturns and adverse developments in the business.
Any or all of the above events or factors could have an adverse effect on our results of operations and financial condition. The risks that we face based on our outstanding indebtedness may intensify if we incur additional indebtedness or financing obligations in the future.
We expect to fund our expenses and to pay the principal and interest on our indebtedness from cash flow from operations. Our ability to meet our expenses and to pay principal and interest on our indebtedness when due depends on our future performance and ability to collect cash from our customers, which will be affected by financial, business, economic, and other factors. We will not be able to control many of these factors, such as economic conditions in the markets where we operate and pressure from competitors.
If our business does not generate sufficient cash flows from operations or if future borrowings are not available to us in an amount sufficient to enable us to pay our indebtedness or to fund our other liquidity needs, we may need to refinance all or a portion of our indebtedness on or before the maturity thereof, sell assets, reduce or delay capital investments, or seek to raise additional capital, any of which could have a material adverse effect on our operations. In addition, we may not be able to effect any of these actions, if necessary, on commercially reasonable terms or at all. Our ability to restructure or refinance our indebtedness will depend on the condition of the capital and debt markets and our financial condition at such time. Any refinancing of our indebtedness could be at higher interest rates and may require us to comply with more onerous covenants, which could further restrict business operations. The terms of anticipated or future debt instruments may limit or prevent us from taking any of these actions.
If there were an event of default under any of the agreements relating to our outstanding indebtedness, the holders of the defaulted debt could cause all amounts outstanding with respect to that debt to be due and payable immediately. We cannot assure you that our assets or cash flow would be sufficient to fully repay borrowings under our outstanding debt instruments if accelerated upon an event of default. Further, if we are unable to repay, refinance or restructure our indebtedness under our secured debt, the holders of such debt could proceed against the collateral securing that indebtedness. In addition, any event of default or declaration of acceleration under one debt instrument could also result in an event of default under one or more of our other debt instruments. As a result, any default by us on our indebtedness could have a material adverse effect on our business and could impact our ability to satisfy the obligations in respect of our indebtedness. In addition, an event of default would likely result in a reduction of our credit rating, which could harm our ability to access additional capital on commercially reasonable terms or at all.
If we experience a significant disruption in our IT systems, our business, reputation, and operating results could be adversely affected. Our business processes depend on our IT systems, and the IT systems and processes of third parties to provide solutions and services, maintain financial records, retain sensitive data such as intellectual property, proprietary business information, and data related to customers, suppliers, and business partners, process orders, manage inventory, process shipments to customers and operate other critical functions. Disruptions to our IT systems from system failures, shutdowns, implementation of new operational systems or software or upgrades to existing systems and software, and other events, including disruptions at our cloud computing, server, systems, and other third party IT service providers, could interfere with our operations, interrupt order processing and shipments, damage customer and business partner relationships, and negatively impact our reputation. Any such event could have a material adverse effect on our business, reputation, operating results and financial condition, and no assurance can be given that our efforts to reduce the risk of such events will be successful.
32

Table of Contents
Defects or errors in the Company’s software products, or third party software included in or upon which our products, solutions and services rely, could harm our reputation, result in significant cost to us, and impair our ability to market such products. Our software, third party software included on our products, solutions or services, or servers and infrastructure may contain undetected errors, defects, or bugs. Although we have not suffered significant harm from any errors, defects, or bugs, we may discover significant errors, defects, or bugs in the future that we may not be able to correct or correct in a timely manner. Any future errors, defects, or bugs found in such software, solutions, services or infrastructure may result in delays in, or loss of market acceptance of, our products, solutions or services; inability to deliver our products, solutions or services; diversion of resources; injury to reputation; increased service and warranty expenses; and payment of damages; which could have a material adverse effect on our financial results.
33

Table of Contents

Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth information with respect to repurchases of the Company’s common stock for the three months ended September 28, 2024:

Period |  | Total Number of Shares Purchased |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions) (1)
June 30, 2024 - July 27, 2024 |  | — |  |  | $ | — |  |  | — |  |  | $ | 893 |
July 28, 2024 - August 24, 2024 |  | 14,081 |  |  | 314.93 |  |  | 14,081 |  |  | 889 |
August 25, 2024 - September 28, 2024 |  | 36,223 |  |  | 327.81 |  |  | 36,223 |  |  | 877 |
Total |  | 50,304 |  |  | $ | 324.20 |  |  | 50,304 |  |  | $ | 877 |

(1)On May 17, 2022, the Company announced that its Board of Directors authorized a share repurchase program for up to $1 billion of its outstanding shares of common stock. This authorization augments the previous $1 billion share repurchase authorization which was announced on July 30, 2019. In the fourth quarter of 2022, the Company completed its original authorization of $1 billion in share repurchases. Repurchases may be affected from time to time through open market purchases, including pursuant to a pre-set trading plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. As of September 28, 2024, the Company has cumulatively repurchased 459,318 shares of common stock for approximately $123 million, resulting in a remaining amount of share repurchases authorized under the May 2022 program of $877 million.

Item 5. | Other Information

None of our directors or executive officers had in effect, adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the third quarter of 2024.
34

Table of Contents

Item 6. | Exhibits

31.1 | Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer
31.2 | Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer
32.1 | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101 | The following financial information from Zebra Technologies Corporation Quarterly Report on Form 10-Q, for the quarter ended September 28, 2024, formatted in Inline XBRL: (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Comprehensive Income; (iv) the Consolidated Statements of Stockholders’ Equity; (v) the Consolidated Statements of Cash Flows; and (vi) Notes to Consolidated Financial Statements. The instance document does not appear in the interactive data file because Inline XBRL tags are embedded in the iXBRL document.
104 | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2024 formatted in Inline XBRL (included in Exhibit 101).

35

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| ZEBRA TECHNOLOGIES CORPORATION
Date: October 29, 2024 | By: |  | /s/ William J. Burns
|  |  | William J. Burns
|  |  | Chief Executive Officer
Date: October 29, 2024 | By: |  | /s/ Nathan Winters
|  |  | Nathan Winters
|  |  | Chief Financial Officer

36